{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T02:54:16Z","timestamp":1777517656142,"version":"3.51.4"},"reference-count":644,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacology &amp; Therapeutics"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1016\/j.pharmthera.2009.11.002","type":"journal-article","created":{"date-parts":[[2009,11,16]],"date-time":"2009-11-16T09:32:16Z","timestamp":1258363936000},"page":"138-168","source":"Crossref","is-referenced-by-count":49,"title":["New horizons for therapeutics in drug and alcohol abuse"],"prefix":"10.1016","volume":"125","author":[{"given":"Bianca","family":"Jupp","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew J.","family":"Lawrence","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.pharmthera.2009.11.002_bib1","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/0006-8993(80)91295-0","article-title":"The action of gamma-vinyl-GABA and gamma-acetylenic-GABA on the resting and stimulated release of GABA in vivo","volume":"191","author":"Abdul-Ghani","year":"1980","journal-title":"Brain Res"},{"issue":"19","key":"10.1016\/j.pharmthera.2009.11.002_bib2","doi-asserted-by":"crossref","first-page":"13361","DOI":"10.1016\/S0021-9258(18)42219-3","article-title":"Molecular characterization of a novel metabotropic glutamate receptor mGluR5 coupled to inositol phosphate\/Ca2+ signal transduction","volume":"267","author":"Abe","year":"1992","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1016\/j.pharmthera.2009.11.002_bib3","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/j.1527-3458.2007.00021.x","article-title":"CGP7930: a positive allosteric modulator of the GABAB receptor","volume":"13","author":"Adams","year":"2007","journal-title":"CNS Drug Rev"},{"issue":"2","key":"10.1016\/j.pharmthera.2009.11.002_bib4","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1017\/S1461145707007845","article-title":"Combined antagonism of glutamate mGlu5 and adenosine A2A receptors interact to regulate alcohol-seeking in rats","volume":"11","author":"Adams","year":"2008","journal-title":"Int J Neuropsychopharmacol"},{"issue":"2\u20133","key":"10.1016\/j.pharmthera.2009.11.002_bib5","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s00213-004-2014-4","article-title":"Tolerance to baclofen's sedative effect in alcohol-addicted patients: no dissipation after a period of abstinence","volume":"178","author":"Addolorato","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"issue":"4","key":"10.1016\/j.pharmthera.2009.11.002_bib6","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/oxfordjournals.alcalc.a008160","article-title":"An open multicentric study evaluating 4-hydroxybutyric acid sodium salt in the medium-term treatment of 179 alcohol dependent subjects. GHB Study Group","volume":"31","author":"Addolorato","year":"1996","journal-title":"Alcohol Alcohol"},{"issue":"9603","key":"10.1016\/j.pharmthera.2009.11.002_bib7","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/S0140-6736(07)61814-5","article-title":"Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled study","volume":"370","author":"Addolorato","year":"2007","journal-title":"Lancet"},{"issue":"5387","key":"10.1016\/j.pharmthera.2009.11.002_bib8","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1126\/science.282.5387.298","article-title":"Transition from moderate to excessive drug intake: change in hedonic set point","volume":"282","author":"Ahmed","year":"1998","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.pharmthera.2009.11.002_bib9","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s00213-005-2180-z","article-title":"Transition to drug addiction: a negative reinforcement model based on an allostatic decrease in reward function","volume":"180","author":"Ahmed","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"issue":"1","key":"10.1016\/j.pharmthera.2009.11.002_bib10","first-page":"38","article-title":"Chronic morphine administration decreases 5-hydroxytryptamine and 2-hydroxyindoleacetic acid content in the brain of rats","volume":"58","author":"Ahtee","year":"1980","journal-title":"Med Biol"},{"key":"10.1016\/j.pharmthera.2009.11.002_bib11","unstructured":"AIHW. (2005). 2004 National drug strategy household survey: Detailed findings Retrieved. from."},{"issue":"1","key":"10.1016\/j.pharmthera.2009.11.002_bib12","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/(SICI)1099-1557(200001\/02)9:1<43::AID-PDS466>3.0.CO;2-R","article-title":"Lofexidine in opiate withdrawal: a safety and usage survey","volume":"9","author":"Akhurst","year":"2000","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"2","key":"10.1016\/j.pharmthera.2009.11.002_bib13","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.pharmthera.2006.08.004","article-title":"Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission","volume":"113","author":"Alex","year":"2007","journal-title":"Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.pharmthera.2009.11.002_bib14","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1124\/jpet.105.086355","article-title":"Effects of the competitive N-methyl-d-aspartate receptor antagonist, LY235959 [(\u2212)-6-phosphonomethyl-deca-hydroisoquinoline-3-carboxylic acid], on responding for cocaine under both fixed and progressive ratio schedules of reinforcement","volume":"315","author":"Allen","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"10.1016\/j.pharmthera.2009.11.002_bib15","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.pbb.2007.07.009","article-title":"Continuous intracerebroventricular infusion of the competitive NMDA receptor antagonist, LY235959, facilitates escalation of cocaine self-administration and increases break point for cocaine in Sprague\u2013Dawley rats","volume":"88","author":"Allen","year":"2007","journal-title":"Pharmacol Biochem Behav"},{"issue":"1","key":"10.1016\/j.pharmthera.2009.11.002_bib16","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jep.2007.08.034","article-title":"The ibogaine medical subculture","volume":"115","author":"Alper","year":"2008","journal-title":"J Ethnopharmacol"},{"issue":"3","key":"10.1016\/j.pharmthera.2009.11.002_bib17","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1080\/105504999305848","article-title":"Treatment of acute opioid withdrawal with ibogaine","volume":"8","author":"Alper","year":"1999","journal-title":"Am J Addict"},{"issue":"1","key":"10.1016\/j.pharmthera.2009.11.002_bib18","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/00005053-199601000-00010","article-title":"A quasi-experimental comparison of the effectiveness of 6- versus 12-hour per week outpatient treatments for cocaine dependence","volume":"184","author":"Alterman","year":"1996","journal-title":"J Nerv Ment Dis"},{"issue":"Suppl 1","key":"10.1016\/j.pharmthera.2009.11.002_bib19","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1007\/s10198-005-0282-5","article-title":"Economic evidence in addiction: a review","volume":"5","author":"Andlin-Sobocki","year":"2004","journal-title":"Eur J Health Econ"},{"issue":"7","key":"10.1016\/j.pharmthera.2009.11.002_bib20","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1038\/sj.npp.1300183","article-title":"Selective antagonism at dopamine D3 receptors prevents nicotine-triggered relapse to nicotine-seeking behavior","volume":"28","author":"Andreoli","year":"2003","journal-title":"Neuropsychopharmacology"},{"issue":"11","key":"10.1016\/j.pharmthera.2009.11.002_bib21","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1176\/ajp.156.11.1758","article-title":"Naltrexone and cognitive behavioral therapy for the treatment of outpatient alcoholics: results of a placebo-controlled trial","volume":"156","author":"Anton","year":"1999","journal-title":"Am J Psychiatry"},{"issue":"1","key":"10.1016\/j.pharmthera.2009.11.002_bib22","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/jcp.0b013e3181602fd4","article-title":"A randomized, multicenter, double-blind, placebo-controlled study of the efficacy and safety of aripiprazole for the treatment of alcohol dependence","volume":"28","author":"Anton","year":"2008","journal-title":"J Clin Psychopharmacol"},{"issue":"17","key":"10.1016\/j.pharmthera.2009.11.002_bib23","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1001\/jama.295.17.2003","article-title":"Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial","volume":"295","author":"Anton","year":"2006","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.pharmthera.2009.11.002_bib24","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1016\/j.biocel.2009.05.015","article-title":"Is the inhibition of nicotinic acetylcholine receptors by bupropion involved in its clinical actions?","volume":"41","author":"Arias","year":"2009","journal-title":"Int J Biochem Cell Biol"},{"issue":"2","key":"10.1016\/j.pharmthera.2009.11.002_bib25","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.pbb.2005.02.015","article-title":"The role of endocannabinoid transmission in cocaine addiction","volume":"81","author":"Arnold","year":"2005","journal-title":"Pharmacol Biochem Behav"},{"issue":"9","key":"10.1016\/j.pharmthera.2009.11.002_bib26","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1097\/01.ALC.0000139821.38167.20","article-title":"Ethanol operant self-administration in rats is regulated by adenosine A2 receptors","volume":"28","author":"Arolfo","year":"2004","journal-title":"Alcohol Clin Exp Res"},{"issue":"2","key":"10.1016\/j.pharmthera.2009.11.002_bib27","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/syn.10052","article-title":"Systemic administration of 1R, 4S-4-amino-cyclopent-2-ene-carboxylic acid, a reversible inhibitor of GABA transaminase, blocks expression of conditioned place preference to cocaine and nicotine in rats","volume":"44","author":"Ashby","year":"2002","journal-title":"Synapse"},{"issue":"4","key":"10.1016\/j.pharmthera.2009.11.002_bib28","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1136\/jme.2003.005017","article-title":"Further ethical and social issues in using a cocaine vaccine: response to Hall and Carter","volume":"30","author":"Ashcroft","year":"2004","journal-title":"J Med Ethics"},{"key":"10.1016\/j.pharmthera.2009.11.002_bib29","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1471-244X-3-16","article-title":"Baclofen for maintenance treatment of opioid dependence: a randomized double-blind placebo-controlled clinical trial [ISRCTN32121581]","volume":"3","author":"Assadi","year":"2003","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.pharmthera.2009.11.002_bib30","doi-asserted-by":"crossref","first-page":"b1979","DOI":"10.1136\/bmj.b1979","article-title":"Nicotine replacement therapy. Authors respond to criticism that treatment is ineffective","volume":"338","author":"Aveyard","year":"2009","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.pharmthera.2009.11.002_bib31","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1046\/j.1471-4159.1996.66020443.x","article-title":"Effect of chronic cocaine treatment on mu- and delta-opioid receptor mRNA levels in dopaminergically innervated brain regions","volume":"66","author":"Azaryan","year":"1996","journal-title":"J Neurochem"},{"issue":"1\u20133","key":"10.1016\/j.pharmthera.2009.11.002_bib32","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ejphar.2005.10.051","article-title":"Suppression of alcohol self-administration and cue-induced reinstatement of alcohol seeking by the mGlu2\/3 receptor agonist LY379268 and the mGlu8 receptor agonist (S)-3, 4-DCPG","volume":"528","author":"Backstrom","year":"2005","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"10.1016\/j.pharmthera.2009.11.002_bib33","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/sj.npp.1300845","article-title":"Ionotropic and metabotropic glutamate receptor antagonism attenuates cue-induced cocaine seeking","volume":"31","author":"Backstrom","year":"2006","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"10.1016\/j.pharmthera.2009.11.002_bib34","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s00213-007-0753-8","article-title":"Involvement of AMPA\/kainate, NMDA, and mGlu5 receptors in the nucleus accumbens core in cue-induced reinstatement of cocaine seeking in rats","volume":"192","author":"Backstrom","year":"2007","journal-title":"Psychopharmacology (Berl)"},{"issue":"5","key":"10.1016\/j.pharmthera.2009.11.002_bib35","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1038\/sj.npp.1300381","article-title":"mGluR5 antagonist MPEP reduces ethanol-seeking and relapse behavior","volume":"29","author":"Backstrom","year":"2004","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.pharmthera.2009.11.002_bib36","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/j.1530-0277.2001.tb02225.x","article-title":"Effect of neuropeptide Y (NPY) on oral ethanol intake in Wistar, alcohol-preferring (P), and -nonpreferring (NP) rats","volume":"25","author":"Badia-Elder","year":"2001","journal-title":"Alcohol Clin Exp Res"},{"issue":"7","key":"10.1016\/j.pharmthera.2009.11.002_bib37","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/nn1069","article-title":"Neuroadaptations in cystine-glutamate exchange underlie cocaine relapse","volume":"6","author":"Baker","year":"2003","journal-title":"Nat Neurosci"},{"issue":"4","key":"10.1016\/j.pharmthera.2009.11.002_bib38","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1080\/00952990701407694","article-title":"Acute cocaine responses following cocaethylene infusion","volume":"33","author":"Baker","year":"2007","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"2","key":"10.1016\/j.pharmthera.2009.11.002_bib39","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/BF02244208","article-title":"CRF antagonist reverses the \u201canxiogenic\u201d response to ethanol withdrawal in the rat","volume":"103","author":"Baldwin","year":"1991","journal-title":"Psychopharmacology (Berl)"},{"issue":"4","key":"10.1016\/j.pharmthera.2009.11.002_bib40","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1055\/s-2005-916219","article-title":"A pilot randomised, open, uncontrolled, clinical study of two dosages of St John's wort (Hypericum perforatum) herb extract (LI-160) as an aid to motivational\/behavioural support in smoking cessation","volume":"72","author":"Barnes","year":"2006","journal-title":"Planta Med"},{"issue":"1","key":"10.1016\/j.pharmthera.2009.11.002_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00008877-200102000-00001","article-title":"The D3R partial agonist, BP 897, attenuates the discriminative stimulus effects of cocaine and d-amphetamine and is not self-administered","volume":"12","author":"Beardsley","year":"2001","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.pharmthera.2009.11.002_bib42","first-page":"34","article-title":"Indian youth and inhalants: an update","volume":"85","author":"Beauvais","year":"1988","journal-title":"NIDA Res Monogr"},{"issue":"1","key":"10.1016\/j.pharmthera.2009.11.002_bib43","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1046\/j.1471-4159.2002.00815.x","article-title":"Functional and molecular characterization of metabotropic glutamate receptors expressed in rat striatal cholinergic interneurones","volume":"81","author":"Bell","year":"2002","journal-title":"J Neurochem"},{"issue":"Suppl 1","key":"10.1016\/j.pharmthera.2009.11.002_bib44","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1360-0443.2005.00983.x","article-title":"A medication screening trial evaluation of reserpine, gabapentin and lamotrigine pharmacotherapy of cocaine dependence","volume":"100","author":"Berger","year":"2005","journal-title":"Addiction"},{"issue":"3","key":"10.1016\/j.pharmthera.2009.11.002_bib45","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1007\/s00213-003-1769-3","article-title":"GABA(B) receptor agonists reduce operant ethanol self-administration and enhance ethanol sedation in C57BL\/6J mice","volume":"174","author":"Besheer","year":"2004","journal-title":"Psychopharmacology (Berl)"},{"issue":"2","key":"10.1016\/j.pharmthera.2009.11.002_bib46","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s00213-005-0284-0","article-title":"Absence of quasi-morphine withdrawal syndrome in adenosine A2A receptor knockout mice","volume":"185","author":"Bilbao","year":"2006","journal-title":"Psychopharmacology (Berl)"},{"issue":"1","key":"10.1016\/j.pharmthera.2009.11.002_bib47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s002130100739","article-title":"The NMDA antagonist memantine attenuates the expression of opioid physical dependence in humans","volume":"157","author":"Bisaga","year":"2001","journal-title":"Psychopharmacology (Berl)"},{"issue":"3","key":"10.1016\/j.pharmthera.2009.11.002_bib48","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.drugalcdep.2005.07.009","article-title":"A randomized placebo-controlled trial of gabapentin for cocaine dependence","volume":"81","author":"Bisaga","year":"2006","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"10.1016\/j.pharmthera.2009.11.002_bib49","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1460-9568.1994.tb00272.x","article-title":"Blockade of prefronto-cortical alpha 1-adrenergic receptors prevents locomotor hyperactivity induced by subcortical d-amphetamine injection","volume":"6","author":"Blanc","year":"1994","journal-title":"Eur J Neurosci"},{"issue":"3","key":"10.1016\/j.pharmthera.2009.11.002_bib50","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0014-2999(96)00583-3","article-title":"Voluntary ethanol intake in the rat: effects of nicotinic acetylcholine receptor blockade or subchronic nicotine treatment","volume":"314","author":"Blomqvist","year":"1996","journal-title":"Eur J Pharmacol"},{"issue":"6","key":"10.1016\/j.pharmthera.2009.11.002_bib51","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.clinthera.2005.06.015","article-title":"Acamprosate for the treatment of alcohol dependence","volume":"27","author":"Boothby","year":"2005","journal-title":"Clin Ther"},{"issue":"2","key":"10.1016\/j.pharmthera.2009.11.002_bib52","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0922-4106(94)90089-2","article-title":"Tiagabine, SK&F 89976-A, CI-966, and NNC-711 are selective for the cloned GABA transporter GAT-1","volume":"269","author":"Borden","year":"1994","journal-title":"Eur J Pharmacol"},{"issue":"9","key":"10.1016\/j.pharmthera.2009.11.002_bib53","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1097\/00001756-200506210-00026","article-title":"The novel mGluR2\/3 agonist LY379268 attenuates cue-induced reinstatement of heroin seeking","volume":"16","author":"Bossert","year":"2005","journal-title":"Neuroreport"},{"issue":"47","key":"10.1016\/j.pharmthera.2009.11.002_bib54","doi-asserted-by":"crossref","first-page":"10726","DOI":"10.1523\/JNEUROSCI.3207-04.2004","article-title":"A role of ventral tegmental area glutamate in contextual cue-induced relapse to heroin seeking","volume":"24","author":"Bossert","year":"2004","journal-title":"J Neurosci"},{"issue":"1","key":"10.1016\/j.pharmthera.2009.11.002_bib55","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s00213-005-0139-8","article-title":"Effects of dopamine beta-hydroxylase genotype and disulfiram inhibition on catecholamine homeostasis in mice","volume":"183","author":"Bourd\u00e9lat-Parks","year":"2005","journal-title":"Psychopharmacology (Berlin)"},{"issue":"4","key":"10.1016\/j.pharmthera.2009.11.002_bib56","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1111\/j.1476-5381.1989.tb12679.x","article-title":"The effects of dihydropyridine compounds in behavioural tests of dopaminergic activity","volume":"98","author":"Bourson","year":"1989","journal-title":"Br J Pharmacol"},{"issue":"6","key":"10.1016\/j.pharmthera.2009.11.002_bib57","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.ntt.2006.09.005","article-title":"The last decade of solvent research in animal models of abuse: mechanistic and behavioral studies","volume":"28","author":"Bowen","year":"2006","journal-title":"Neurotoxicol Teratol"},{"issue":"12","key":"10.1016\/j.pharmthera.2009.11.002_bib58","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1111\/j.1530-0277.2006.00241.x","article-title":"Ethanol-related behaviors in serotonin transporter knockout mice","volume":"30","author":"Boyce-Rustay","year":"2006","journal-title":"Alcohol Clin Exp Res"},{"issue":"3","key":"10.1016\/j.pharmthera.2009.11.002_bib59","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1037\/1064-1297.10.3.276","article-title":"Carbamazepine in the treatment of cocaine dependence: subtyping by affective disorder","volume":"10","author":"Brady","year":"2002","journal-title":"Exp Clin Psychopharmacol"},{"issue":"11","key":"10.1016\/j.pharmthera.2009.11.002_bib60","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1016\/S0028-3908(99)00094-5","article-title":"The GABA(B) agonist CGP 44532 decreases cocaine self-administration in rats: demonstration using a progressive ratio and a discrete trials procedure","volume":"38","author":"Brebner","year":"1999","journal-title":"Neuropharmacology"},{"issue":"3","key":"10.1016\/j.pharmthera.2009.11.002_bib61","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/syn.10278","article-title":"Treating cocaine addiction: from preclinical to clinical trial experience with gamma-vinyl GABA","volume":"50","author":"Brodie","year":"2003","journal-title":"Synapse"},{"issue":"2","key":"10.1016\/j.pharmthera.2009.11.002_bib62","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/syn.20097","article-title":"Safety and efficacy of gamma-vinyl GABA (GVG) for the treatment of methamphetamine and\/or cocaine addiction","volume":"55","author":"Brodie","year":"2005","journal-title":"Synapse"},{"issue":"2","key":"10.1016\/j.pharmthera.2009.11.002_bib63","doi-asserted-by":"crossref","first-page":"197","DOI":"10.4088\/JCP.v64n0213","article-title":"Lamotrigine in patients with bipolar disorder and cocaine dependence","volume":"64","author":"Brown","year":"2003","journal-title":"J Clin Psychiatry"},{"issue":"4","key":"10.1016\/j.pharmthera.2009.11.002_bib64","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/npp.2008.72","article-title":"A differential role for the adenosine A2A receptor in opiate reinforcement vs opiate-seeking behavior","volume":"34","author":"Brown","year":"2009","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.pharmthera.2009.11.002_bib65","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00213-008-1376-4","article-title":"Interaction between noradrenaline and corticotrophin-releasing factor in the reinstatement of cocaine seeking in the rat","volume":"203","author":"Brown","year":"2009","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pharmthera.2009.11.002_bib66","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0079-6123(08)00916-3","article-title":"Prospects for serotonin 5-HT2R pharmacotherapy in psychostimulant abuse","volume":"172","author":"Bubar","year":"2008","journal-title":"Prog Brain Res"},{"issue":"3","key":"10.1016\/j.pharmthera.2009.11.002_bib67","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/01.yco.0000218592.00689.e5","article-title":"The cannabis withdrawal syndrome","volume":"19","author":"Budney","year":"2006","journal-title":"Curr Opin Psychiatry"},{"issue":"11","key":"10.1016\/j.pharmthera.2009.11.002_bib68","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1176\/appi.ajp.161.11.1967","article-title":"Review of the validity and significance of cannabis withdrawal syndrome","volume":"161","author":"Budney","year":"2004","journal-title":"Am J Psychiatry"},{"issue":"4","key":"10.1016\/j.pharmthera.2009.11.002_bib69","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/sj.npp.1300346","article-title":"Differential roles of 5-HT receptor subtypes in cue and cocaine reinstatement of cocaine-seeking behavior in rats","volume":"29","author":"Burmeister","year":"2004","journal-title":"Neuropsychopharmacology"},{"issue":"1\u20133","key":"10.1016\/j.pharmthera.2009.11.002_bib70","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ejphar.2005.08.016","article-title":"Monoclonal IgG affinity and treatment time alters antagonism of (+)-methamphetamine effects in rats","volume":"521","author":"Byrnes-Blake","year":"2005","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2009.11.002_bib71","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/978-0-387-78748-0_6","article-title":"The role of nicotine in smoking: a dual-reinforcement model","volume":"55","author":"Caggiula","year":"2009","journal-title":"Nebr Symp Motiv"},{"key":"10.1016\/j.pharmthera.2009.11.002_bib72","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005353.pub3","article-title":"Cannabinoid type 1 receptor antagonists (rimonabant) for smoking cessation","volume":"4","author":"Cahill","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.pharmthera.2009.11.002_bib73","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006103.pub2","article-title":"Nicotine receptor partial agonists for smoking cessation","volume":"1","author":"Cahill","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"issue":"5115","key":"10.1016\/j.pharmthera.2009.11.002_bib74","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1126\/science.8099761","article-title":"Modulation of cocaine self-administration in the rat through D-3 dopamine receptors","volume":"260","author":"Caine","year":"1993","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.pharmthera.2009.11.002_bib75","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/0024-3205(94)00414-N","article-title":"Blockade of cocaine-induced conditioned place preference: relevance to cocaine abuse therapeutics","volume":"56","author":"Calcagnetti","year":"1995","journal-title":"Life Sci"},{"issue":"11 Pt 1","key":"10.1016\/j.pharmthera.2009.11.002_bib76","doi-asserted-by":"crossref","first-page":"6763","DOI":"10.1523\/JNEUROSCI.14-11-06763.1994","article-title":"Cocaine inhibits GABA release in the VTA through endogenous 5-HT","volume":"14","author":"Cameron","year":"1994","journal-title":"J Neurosci"},{"issue":"2","key":"10.1016\/j.pharmthera.2009.11.002_bib77","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1521-0391.2003.tb00610.x","article-title":"Comparison of desipramine or carbamazepine to placebo for crack cocaine-dependent patients","volume":"12","author":"Campbell","year":"2003","journal-title":"Am J Addict"},{"issue":"4","key":"10.1016\/j.pharmthera.2009.11.002_bib78","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1300\/J069v13n04_07","article-title":"Impact of desipramine or carbamazepine on patient retention in outpatient cocaine treatment: preliminary findings","volume":"13","author":"Campbell","year":"1994","journal-title":"J Addict Dis"},{"issue":"1\u20132","key":"10.1016\/j.pharmthera.2009.11.002_bib79","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s00213-002-1283-z","article-title":"A role for the prefrontal cortex in stress- and cocaine-induced reinstatement of cocaine seeking in rats","volume":"168","author":"Capriles","year":"2003","journal-title":"Psychopharmacology (Berl)"},{"issue":"3","key":"10.1016\/j.pharmthera.2009.11.002_bib80","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/0014-2999(89)90259-8","article-title":"Differential inhibitory effects of a 5-HT3 antagonist on drug-induced stimulation of dopamine release","volume":"164","author":"Carboni","year":"1989","journal-title":"Eur J Pharmacol"},{"issue":"6558","key":"10.1016\/j.pharmthera.2009.11.002_bib81","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/378727a0","article-title":"Suppression of psychoactive effects of cocaine by active immunization","volume":"378","author":"Carrera","year":"1995","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.pharmthera.2009.11.002_bib82","doi-asserted-by":"crossref","first-page":"6202","DOI":"10.1073\/pnas.97.11.6202","article-title":"Cocaine vaccines: antibody protection against relapse in a rat model","volume":"97","author":"Carrera","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2009.11.002_bib83","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1196\/annals.1441.015","article-title":"Antagonists at metabotropic glutamate receptor subtype 5: structure activity relationships and therapeutic potential for addiction","volume":"1141","author":"Carroll","year":"2008","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"10.1016\/j.pharmthera.2009.11.002_bib84","doi-asserted-by":"crossref","first-page":"E196","DOI":"10.1208\/aapsj080124","article-title":"Development of the dopamine transporter selective RTI-336 as a pharmacotherapy for cocaine abuse","volume":"8","author":"Carroll","year":"2006","journal-title":"AAPS J"},{"issue":"1","key":"10.1016\/j.pharmthera.2009.11.002_bib85","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/BF00443407","article-title":"A concurrently available nondrug reinforcer prevents the acquisition or decreases the maintenance of cocaine-reinforced behavior","volume":"97","author":"Carroll","year":"1989","journal-title":"Psychopharmacology (Berl)"},{"issue":"3","key":"10.1016\/j.pharmthera.2009.11.002_bib86","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/BF02244596","article-title":"Intravenous cocaine self-administration in rats is reduced by dietary l-tryptophan","volume":"100","author":"Carroll","year":"1990","journal-title":"Psychopharmacology (Berl)"},{"issue":"5","key":"10.1016\/j.pharmthera.2009.11.002_bib87","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S0028-3908(02)00118-1","article-title":"Lack of CB1 cannabinoid receptors modifies nicotine behavioural responses, but not nicotine abstinence","volume":"43","author":"Castane","year":"2002","journal-title":"Neuropharmacology"},{"issue":"5","key":"10.1016\/j.pharmthera.2009.11.002_bib88","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/bjp.2008.299","article-title":"Behavioural and biochemical responses to morphine associated with its motivational properties are altered in adenosine A(2A) receptor knockout mice","volume":"155","author":"Castane","year":"2008","journal-title":"Br J Pharmacol"},{"issue":"2","key":"10.1016\/j.pharmthera.2009.11.002_bib89","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/s00213-003-1492-0","article-title":"Hypericum perforatum attenuates nicotine withdrawal signs in mice","volume":"169","author":"Catania","year":"2003","journal-title":"Psychopharmacology (Berl)"},{"issue":"3","key":"10.1016\/j.pharmthera.2009.11.002_bib90","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/BF00427109","article-title":"Evidence of a preferential role of brain serotonin in the mechanisms leading to naloxone-precipitated compulsive jumping in morphine-dependent rats","volume":"74","author":"Cervo","year":"1981","journal-title":"Psychopharmacology (Berl)"},{"issue":"6","key":"10.1016\/j.pharmthera.2009.11.002_bib91","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1038\/sj.npp.1300169","article-title":"Cocaine-seeking behavior in response to drug-associated stimuli in rats: involvement of D3 and D2 dopamine receptors","volume":"28","author":"Cervo","year":"2003","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"10.1016\/j.pharmthera.2009.11.002_bib92","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.pbb.2005.11.015","article-title":"Selective antagonist at D3 receptors, but not non-selective partial agonists, influences the expression of cocaine-induced conditioned place preference in free-feeding rats","volume":"82","author":"Cervo","year":"2005","journal-title":"Pharmacol Biochem Behav"},{"issue":"2","key":"10.1016\/j.pharmthera.2009.11.002_bib93","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1017\/S1461145705006449","article-title":"Selective antagonism at dopamine D3 receptors attenuates cocaine-seeking behaviour in the rat","volume":"10","author":"Cervo","year":"2007","journal-title":"Int J Neuropsychopharmacol"},{"issue":"3\u20134","key":"10.1016\/j.pharmthera.2009.11.002_bib94","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3109\/00952999009001589","article-title":"A double-blind amino acids, l-tryptophan and l-tyrosine, and placebo study with cocaine-dependent subjects in an inpatient chemical dependency treatment center","volume":"16","author":"Chadwick","year":"1990","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"4","key":"10.1016\/j.pharmthera.2009.11.002_bib95","doi-asserted-by":"crossref","first-page":"269","DOI":"10.5694\/j.1326-5377.1991.tb121089.x","article-title":"Volatile substance abuse","volume":"154","author":"Chalmers","year":"1991","journal-title":"Med J Aust"},{"key":"10.1016\/j.pharmthera.2009.11.002_bib96","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/j.1749-6632.1990.tb16910.x","article-title":"Serotonin function and human anxiety disorders","volume":"600","author":"Charney","year":"1990","journal-title":"Ann N Y Acad Sci"},{"issue":"24","key":"10.1016\/j.pharmthera.2009.11.002_bib97","doi-asserted-by":"crossref","first-page":"6450","DOI":"10.1523\/JNEUROSCI.0491-06.2006","article-title":"Behavioral and molecular effects of dopamine D1 receptor stimulation during naloxone-precipitated morphine withdrawal","volume":"26","author":"Chartoff","year":"2006","journal-title":"J Neurosci"},{"issue":"4","key":"10.1016\/j.pharmthera.2009.11.002_bib98","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0092-8674(00)81973-X","article-title":"Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation","volume":"98","author":"Chemelli","year":"1999","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.pharmthera.2009.11.002_bib99","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0893-133X(02)00302-0","article-title":"Effect of selective blockade of mu(1) or delta opioid receptors on reinstatement of alcohol-seeking behavior by drug-associated stimuli in rats","volume":"27","author":"Ciccocioppo","year":"2002","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.pharmthera.2009.11.002_bib100","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s00213-003-1645-1","article-title":"Attenuation of ethanol self-administration and of conditioned reinstatement of alcohol-seeking behaviour by the antiopioid peptide nociceptin\/orphanin FQ in alcohol-preferring rats","volume":"172","author":"Ciccocioppo","year":"2004","journal-title":"Psychopharmacology (Berl)"},{"issue":"Suppl 1","key":"10.1016\/j.pharmthera.2009.11.002_bib101","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1360-0443.2005.00985.x","article-title":"Efficacy screening trials of paroxetine, pentoxifylline, riluzole, pramipexole and venlafaxine in cocaine dependence","volume":"100","author":"Ciraulo","year":"2005","journal-title":"Addiction"},{"key":"10.1016\/j.pharmthera.2009.11.002_bib102","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002210","article-title":"LAAM maintenance vs methadone maintenance for heroin dependence","volume":"2","author":"Clark","year":"2002","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"10.1016\/j.pharmthera.2009.11.002_bib103","doi-asserted-by":"crossref","first-page":"3474","DOI":"10.1021\/jm050069n","article-title":"Varenicline: an alpha4beta2 nicotinic receptor partial agonist for smoking cessation","volume":"48","author":"Coe","year":"2005","journal-title":"J Med Chem"},{"issue":"2","key":"10.1016\/j.pharmthera.2009.11.002_bib104","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.pbb.2005.01.024","article-title":"CB1 receptor antagonists for the treatment of nicotine addiction","volume":"81","author":"Cohen","year":"2005","journal-title":"Pharmacol Biochem Behav"},{"issue":"3","key":"10.1016\/j.pharmthera.2009.11.002_bib105","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0091-3057(99)00103-3","article-title":"Reduction of oral ethanol self-administration in rats by monoamine oxidase inhibitors","volume":"64","author":"Cohen","year":"1999","journal-title":"Pharmacol Biochem Behav"},{"issue":"1","key":"10.1016\/j.pharmthera.2009.11.002_bib106","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1124\/jpet.103.049262","article-title":"SSR591813, a novel selective and partial alpha4beta2 nicotinic receptor agonist with potential as an aid to smoking cessation","volume":"306","author":"Cohen","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"10.1016\/j.pharmthera.2009.11.002_bib107","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00213-003-1397-y","article-title":"Baclofen suppresses motivation to consume alcohol in rats","volume":"167","author":"Colombo","year":"2003","journal-title":"Psychopharmacology (Berl)"},{"issue":"1","key":"10.1016\/j.pharmthera.2009.11.002_bib108","first-page":"58","article-title":"Ability of baclofen in reducing alcohol intake and withdrawal severity: I-Preclinical evidence","volume":"24","author":"Colombo","year":"2000","journal-title":"Alcohol Clin Exp Res"},{"issue":"2","key":"10.1016\/j.pharmthera.2009.11.002_bib109","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s00213-007-0775-2","article-title":"Memantine produces modest reductions in heroin-induced subjective responses in human research volunteers","volume":"193","author":"Comer","year":"2007","journal-title":"Psychopharmacology (Berl)"},{"issue":"2","key":"10.1016\/j.pharmthera.2009.11.002_bib110","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1001\/archpsyc.63.2.210","article-title":"Injectable, sustained-release naltrexone for the treatment of opioid dependence: a randomized, placebo-controlled trial","volume":"63","author":"Comer","year":"2006","journal-title":"Arch Gen Psychiatry"},{"issue":"5","key":"10.1016\/j.pharmthera.2009.11.002_bib111","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1001\/archpsyc.64.5.566","article-title":"Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: results from the national epidemiologic survey on alcohol and related conditions","volume":"64","author":"Compton","year":"2007","journal-title":"Arch Gen Psychiatry"},{"issue":"51","key":"10.1016\/j.pharmthera.2009.11.002_bib112","doi-asserted-by":"crossref","first-page":"18649","DOI":"10.1073\/pnas.0506999102","article-title":"The corticotropin-releasing factor receptor-1 pathway mediates the negative affective states of opiate withdrawal","volume":"102","author":"Contarino","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1\u20132","key":"10.1016\/j.pharmthera.2009.11.002_bib113","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s00213-003-1711-8","article-title":"Influence of fluoxetine on positive and negative affect in a clinic-based smoking cessation trial","volume":"173","author":"Cook","year":"2004","journal-title":"Psychopharmacology (Berl)"},{"issue":"4","key":"10.1016\/j.pharmthera.2009.11.002_bib114","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/S0306-4522(99)00214-6","article-title":"A role for nucleus accumbens glutamate transmission in the relapse to cocaine-seeking behavior","volume":"93","author":"Cornish","year":"1999","journal-title":"Neuroscience"},{"issue":"2","key":"10.1016\/j.pharmthera.2009.11.002_bib115","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0376-8716(00)00140-X","article-title":"A randomized, double-blind, placebo-controlled study of ritanserin pharmacotherapy for cocaine dependence","volume":"61","author":"Cornish","year":"2001","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"10.1016\/j.pharmthera.2009.11.002_bib116","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0376-8716(95)01102-5","article-title":"Carbamazepine treatment for cocaine dependence","volume":"38","author":"Cornish","year":"1995","journal-title":"Drug Alcohol Depend"},{"issue":"6","key":"10.1016\/j.pharmthera.2009.11.002_bib117","doi-asserted-by":"crossref","first-page":"e2547","DOI":"10.1371\/journal.pone.0002547","article-title":"A vaccine against nicotine for smoking cessation: a randomized controlled trial","volume":"3","author":"Cornuz","year":"2008","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1016\/j.pharmthera.2009.11.002_bib118","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/BF02244173","article-title":"Opiate antagonists reduce cocaine but not nicotine self-administration","volume":"104","author":"Corrigall","year":"1991","journal-title":"Psychopharmacology (Berl)"},{"issue":"1","key":"10.1016\/j.pharmthera.2009.11.002_bib119","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0166-4328(00)00311-9","article-title":"Cannabinoid CB1 receptor knockout mice fail to self-administer morphine but not other drugs of abuse","volume":"118","author":"Cossu","year":"2001","journal-title":"Behav Brain Res"},{"issue":"2","key":"10.1016\/j.pharmthera.2009.11.002_bib120","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1080\/14622200110042624","article-title":"Effects of a single dose of baclofen on self-reported subjective effects and tobacco smoking","volume":"3","author":"Cousins","year":"2001","journal-title":"Nicotine Tob Res"},{"issue":"3","key":"10.1016\/j.pharmthera.2009.11.002_bib121","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0376-8716(01)00163-6","article-title":"GABA(B) receptor agonists for the treatment of drug addiction: a review of recent findings","volume":"65","author":"Cousins","year":"2002","journal-title":"Drug Alcohol Depend"},{"issue":"4","key":"10.1016\/j.pharmthera.2009.11.002_bib122","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/j.1476-5381.1977.tb07532.x","article-title":"Agonist and antagonist properties of buprenorphine, a new antinociceptive agent","volume":"60","author":"Cowan","year":"1977","journal-title":"Br J Pharmacol"},{"issue":"7","key":"10.1016\/j.pharmthera.2009.11.002_bib123","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/S0278-5846(99)00060-3","article-title":"The role of opioid-dopamine interactions in the induction and maintenance of ethanol consumption","volume":"23","author":"Cowen","year":"1999","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"2","key":"10.1016\/j.pharmthera.2009.11.002_bib124","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1124\/jpet.105.090449","article-title":"The metabotropic glutamate 5 receptor antagonist 3-[(2-methyl-1, 3-thiazol-4-yl)ethynyl]-pyridine reduces ethanol self-administration in multiple strains of alcohol-preferring rats and regulates olfactory glutamatergic systems","volume":"315","author":"Cowen","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"10.1016\/j.pharmthera.2009.11.002_bib125","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1080\/13556210500223132","article-title":"The acute anti-craving effect of acamprosate in alcohol-preferring rats is associated with modulation of the mesolimbic dopamine system","volume":"10","author":"Cowen","year":"2005","journal-title":"Addict Biol"},{"issue":"4","key":"10.1016\/j.pharmthera.2009.11.002_bib126","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1300\/J069v10n04_02","article-title":"Pharmacotherapeutic interventions for cocaine abuse: present practices and future directions","volume":"10","author":"Crosby","year":"1991","journal-title":"J Addict Dis"},{"issue":"3","key":"10.1016\/j.pharmthera.2009.11.002_bib127","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1080\/09595230801935672","article-title":"A placebo-controlled trial of mirtazapine for the management of methamphetamine withdrawal","volume":"27","author":"Cruickshank","year":"2008","journal-title":"Drug Alcohol Rev"},{"issue":"1","key":"10.1016\/j.pharmthera.2009.11.002_bib128","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0741-8329(02)00236-7","article-title":"Separate measures of ethanol seeking and drinking in the rat: effects of remoxipride","volume":"28","author":"Czachowski","year":"2002","journal-title":"Alcohol"},{"issue":"3","key":"10.1016\/j.pharmthera.2009.11.002_bib129","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1124\/jpet.300.3.831","article-title":"Serotonergic attenuation of the reinforcing and neurochemical effects of cocaine in squirrel monkeys","volume":"300","author":"Czoty","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"10.1016\/j.pharmthera.2009.11.002_bib130","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/sj.npp.1300600","article-title":"A double-blind, placebo-controlled trial of modafinil for cocaine dependence","volume":"30","author":"Dackis","year":"2005","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.pharmthera.2009.11.002_bib131","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0376-8716(02)00335-6","article-title":"Modafinil and cocaine: a double-blind, placebo-controlled drug interaction study","volume":"70","author":"Dackis","year":"2003","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.pharmthera.2009.11.002_bib132","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003086.pub2","article-title":"Opioid antagonists for smoking cessation","volume":"4","author":"David","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"issue":"9","key":"10.1016\/j.pharmthera.2009.11.002_bib133","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.2217\/14622416.9.9.1307","article-title":"Genetic variation in the dopamine pathway and smoking cessation","volume":"9","author":"David","year":"2008","journal-title":"Pharmacogenomics"},{"issue":"4\u20136","key":"10.1016\/j.pharmthera.2009.11.002_bib134","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0893-6080(02)00052-7","article-title":"Opponent interactions between serotonin and dopamine","volume":"15","author":"Daw","year":"2002","journal-title":"Neural Netw"},{"issue":"6","key":"10.1016\/j.pharmthera.2009.11.002_bib135","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.addbeh.2004.10.011","article-title":"A prospective, open-label trial of ondansetron in adolescents with alcohol dependence","volume":"30","author":"Dawes","year":"2005","journal-title":"Addict Behav"},{"issue":"2","key":"10.1016\/j.pharmthera.2009.11.002_bib136","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.biopsych.2007.02.002","article-title":"Stimuli linked to ethanol availability activate hypothalamic CART and orexin neurons in a reinstatement model of relapse","volume":"63","author":"Dayas","year":"2008","journal-title":"Biol Psychiatry"},{"issue":"Suppl 4","key":"10.1016\/j.pharmthera.2009.11.002_bib137","first-page":"19","article-title":"The pharmacologic profile of mirtazapine","volume":"57","author":"de Boer","year":"1996","journal-title":"J Clin Psychiatry"},{"issue":"2","key":"10.1016\/j.pharmthera.2009.11.002_bib138","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.pbb.2007.12.010","article-title":"The acetylcholinesterase inhibitor rivastigmine does not alter total choices for methamphetamine, but may reduce positive subjective effects, in a laboratory model of intravenous self-administration in human volunteers","volume":"89","author":"De La Garza","year":"2008","journal-title":"Pharmacol Biochem Behav"},{"issue":"10","key":"10.1016\/j.pharmthera.2009.11.002_bib139","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1038\/nm1001-1151","article-title":"A cannabinoid mechanism in relapse to cocaine seeking","volume":"7","author":"De Vries","year":"2001","journal-title":"Nat Med"},{"issue":"4","key":"10.1016\/j.pharmthera.2009.11.002_bib140","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1093\/alcalc\/37.4.375","article-title":"Does psychosocial treatment enhance the efficacy of acamprosate in patients with alcohol problems?","volume":"37","author":"De Wildt","year":"2002","journal-title":"Alcohol Alcohol"},{"issue":"6","key":"10.1016\/j.pharmthera.2009.11.002_bib141","doi-asserted-by":"crossref","first-page":"517","DOI":"10.2165\/00023210-200519060-00004","article-title":"Neuroprotective and abstinence-promoting effects of acamprosate: elucidating the mechanism of action","volume":"19","author":"De Witte","year":"2005","journal-title":"CNS Drugs"},{"issue":"1\u20133","key":"10.1016\/j.pharmthera.2009.11.002_bib142","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ejphar.2004.01.018","article-title":"Mirtazapine-induced corelease of dopamine and noradrenaline from noradrenergic neurons in the medial prefrontal and occipital cortex","volume":"487","author":"Devoto","year":"2004","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"10.1016\/j.pharmthera.2009.11.002_bib143","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/sj.npp.1300148","article-title":"Attenuation of cue-controlled cocaine-seeking by a selective D3 dopamine receptor antagonist SB-277011-A","volume":"28","author":"Di Ciano","year":"2003","journal-title":"Neuropsychopharmacology"},{"issue":"17","key":"10.1016\/j.pharmthera.2009.11.002_bib144","doi-asserted-by":"crossref","first-page":"7966","DOI":"10.1073\/pnas.90.17.7966","article-title":"Profound decrement of mesolimbic dopaminergic neuronal activity during ethanol withdrawal syndrome in rats: electrophysiological and biochemical evidence","volume":"90","author":"Diana","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.pharmthera.2009.11.002_bib145","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/syn.20279","article-title":"Morphine withdrawal syndrome and its prevention with baclofen: Autoradiographic study of mu-opioid receptors in prepubertal male and female mice","volume":"60","author":"Diaz","year":"2006","journal-title":"Synapse"},{"issue":"6 Suppl 4","key":"10.1016\/j.pharmthera.2009.11.002_bib146","doi-asserted-by":"crossref","first-page":"S233","DOI":"10.1212\/WNL.47.6_Suppl_4.233S","article-title":"The pharmacology and mechanism of action of riluzole","volume":"47","author":"Doble","year":"1996","journal-title":"Neurology"},{"issue":"20","key":"10.1016\/j.pharmthera.2009.11.002_bib147","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1001\/jama.260.20.3025","article-title":"Implications of methadone maintenance for theories of narcotic addiction","volume":"260","author":"Dole","year":"1988","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.pharmthera.2009.11.002_bib148","doi-asserted-by":"crossref","first-page":"165","DOI":"10.2174\/138945006775515491","article-title":"Modulation of dopamine transmission by 5HT2C and 5HT3 receptors: a role in the antidepressant response","volume":"7","author":"Dremencov","year":"2006","journal-title":"Curr Drug Targets"},{"issue":"11","key":"10.1016\/j.pharmthera.2009.11.002_bib149","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1038\/sj.npp.1300276","article-title":"Effects of a dopamine D3 receptor ligand, BP 897, on acquisition and expression of food-, morphine-, and cocaine-induced conditioned place preference, and food-seeking behavior in rats","volume":"28","author":"Duarte","year":"2003","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.pharmthera.2009.11.002_bib150","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/BF02246099","article-title":"Effects of ibogaine on responding maintained by food, cocaine and heroin reinforcement in rats","volume":"117","author":"Dworkin","year":"1995","journal-title":"Psychopharmacology (Berl)"},{"issue":"3","key":"10.1016\/j.pharmthera.2009.11.002_bib151","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.biopsych.2008.02.004","article-title":"Dysregulation of nociceptin\/orphanin FQ activity in the amygdala is linked to excessive alcohol drinking in the rat","volume":"64","author":"Economidou","year":"2008","journal-title":"Biol Psychiatry"},{"issue":"8","key":"10.1016\/j.pharmthera.2009.11.002_bib152","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1111\/j.1360-0443.2005.001128.x","article-title":"Comparative study of the effectiveness of slow-release morphine and methadone for opioid maintenance therapy","volume":"100","author":"Eder","year":"2005","journal-title":"Addiction"},{"issue":"1","key":"10.1016\/j.pharmthera.2009.11.002_bib153","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1360-0443.2004.00611.x","article-title":"Does disulfiram have a role in alcoholism treatment today? Not to forget about disulfiram's psychological effects","volume":"99","author":"Ehrenreich","year":"2004","journal-title":"Addiction"},{"issue":"3","key":"10.1016\/j.pharmthera.2009.11.002_bib154","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0376-8716(96)01278-1","article-title":"Failure of ritanserin to block cocaine cue reactivity in humans","volume":"42","author":"Ehrman","year":"1996","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"10.1016\/j.pharmthera.2009.11.002_bib155","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1503\/cmaj.070256","article-title":"Pharmacotherapies for smoking cessation: a meta-analysis of randomized controlled trials","volume":"179","author":"Eisenberg","year":"2008","journal-title":"CMAJ"},{"issue":"3","key":"10.1016\/j.pharmthera.2009.11.002_bib156","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.drugalcdep.2006.04.010","article-title":"Double-blind, placebo-controlled trial of selegiline transdermal system (STS) for the treatment of cocaine dependence","volume":"85","author":"Elkashef","year":"2006","journal-title":"Drug Alcohol Depend"},{"issue":"Suppl 1","key":"10.1016\/j.pharmthera.2009.11.002_bib157","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1360-0443.2007.01779.x","article-title":"The NIDA Methamphetamine Clinical Trials Group: a strategy to increase clinical trials research capacity","volume":"102","author":"Elkashef","year":"2007","journal-title":"Addiction"},{"key":"10.1016\/j.pharmthera.2009.11.002_bib158","unstructured":"EMCDDA. (2008). 2008 Annual Report: The state of the drugs problem in Europe. Retrieved. from."},{"issue":"14","key":"10.1016\/j.pharmthera.2009.11.002_bib159","doi-asserted-by":"crossref","first-page":"5529","DOI":"10.1523\/JNEUROSCI.18-14-05529.1998","article-title":"The role of corticotropin-releasing factor and corticosterone in stress- and cocaine-induced relapse to cocaine seeking in rats","volume":"18","author":"Erb","year":"1998","journal-title":"J Neurosci"},{"issue":"3","key":"10.1016\/j.pharmthera.2009.11.002_bib160","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0014-2999(98)00602-5","article-title":"Voluntary ethanol intake in the rat and the associated accumbal dopamine overflow are blocked by ventral tegmental mecamylamine","volume":"358","author":"Ericson","year":"1998","journal-title":"Eur J Pharmacol"},{"issue":"1\u20133","key":"10.1016\/j.pharmthera.2009.11.002_bib161","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0014-2999(03)01564-4","article-title":"Ethanol elevates accumbal dopamine levels via indirect activation of ventral tegmental nicotinic acetylcholine receptors","volume":"467","author":"Ericson","year":"2003","journal-title":"Eur J Pharmacol"},{"issue":"15","key":"10.1016\/j.pharmthera.2009.11.002_bib162","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1001\/archinte.166.15.1553","article-title":"Cytisine for smoking cessation: a literature review and a meta-analysis","volume":"166","author":"Etter","year":"2006","journal-title":"Arch Intern Med"},{"issue":"1\u20133","key":"10.1016\/j.pharmthera.2009.11.002_bib163","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.drugalcdep.2007.06.017","article-title":"Cytisine for smoking cessation: a research agenda","volume":"92","author":"Etter","year":"2008","journal-title":"Drug Alcohol Depend"},{"issue":"5","key":"10.1016\/j.pharmthera.2009.11.002_bib164","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1111\/j.1530-0277.2007.00360.x","article-title":"A pilot double-blind treatment trial of memantine for alcohol dependence","volume":"31","author":"Evans","year":"2007","journal-title":"Alcohol Clin Exp Res"},{"issue":"2\u20133","key":"10.1016\/j.pharmthera.2009.11.002_bib165","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0165-0173(01)00088-1","article-title":"The neuropsychological basis of addictive behaviour","volume":"36","author":"Everitt","year":"2001","journal-title":"Brain Res Brain Res Rev"},{"issue":"1507","key":"10.1016\/j.pharmthera.2009.11.002_bib166","doi-asserted-by":"crossref","first-page":"3125","DOI":"10.1098\/rstb.2008.0089","article-title":"Review. Neural mechanisms underlying the vulnerability to develop compulsive drug-seeking habits and addiction","volume":"363","author":"Everitt","year":"2008","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"issue":"2","key":"10.1016\/j.pharmthera.2009.11.002_bib167","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0306-4522(02)00017-9","article-title":"Anatomical substrates of orexin-dopamine interactions: lateral hypothalamic projections to the ventral tegmental area","volume":"111","author":"Fadel","year":"2002","journal-title":"Neuroscience"},{"issue":"4","key":"10.1016\/j.pharmthera.2009.11.002_bib168","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1093\/alcalc\/agm047","article-title":"Topiramate (Topamax) reduces conditioned abstinence behaviours and handling-induced convulsions (HIC) after chronic administration of alcohol in Swiss\u2013Webster mice","volume":"42","author":"Farook","year":"2007","journal-title":"Alcohol Alcohol"},{"issue":"2","key":"10.1016\/j.pharmthera.2009.11.002_bib169","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0022-3956(90)90057-W","article-title":"Neuroendocrine effects of S-adenosyl-l-methionine, a novel putative antidepressant","volume":"24","author":"Fava","year":"1990","journal-title":"J Psychiatr Res"},{"issue":"7","key":"10.1016\/j.pharmthera.2009.11.002_bib170","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/0006-2952(79)90293-4","article-title":"Cumulative effects of irreversible MAO inhibitors in vivo","volume":"28","author":"Felner","year":"1979","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"10.1016\/j.pharmthera.2009.11.002_bib171","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbr.2006.06.039","article-title":"Potentiation of cue-induced reinstatement of cocaine-seeking in rats by the anxiogenic drug yohimbine","volume":"174","author":"Feltenstein","year":"2006","journal-title":"Behav Brain Res"},{"issue":"2","key":"10.1016\/j.pharmthera.2009.11.002_bib172","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/bjp.2008.51","article-title":"The neurocircuitry of addiction: an overview","volume":"154","author":"Feltenstein","year":"2008","journal-title":"Br J Pharmacol"},{"issue":"13","key":"10.1016\/j.pharmthera.2009.11.002_bib173","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1126\/science.174.4013.1023","article-title":"Brain serotonin content: increase following ingestion of carbohydrate diet","volume":"174","author":"Fernstrom","year":"1971","journal-title":"Science"},{"issue":"13","key":"10.1016\/j.pharmthera.2009.11.002_bib174","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1097\/00001756-199709080-00016","article-title":"The antinarcoleptic drug modafinil increases glutamate release in thalamic areas and hippocampus","volume":"8","author":"Ferraro","year":"1997","journal-title":"Neuroreport"},{"issue":"2","key":"10.1016\/j.pharmthera.2009.11.002_bib175","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0304-3940(98)00629-6","article-title":"The effects of modafinil on striatal, pallidal and nigral GABA and glutamate release in the conscious rat: evidence for a preferential inhibition of striato-pallidal GABA transmission","volume":"253","author":"Ferraro","year":"1998","journal-title":"Neurosci Lett"},{"issue":"5","key":"10.1016\/j.pharmthera.2009.11.002_bib176","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.pneurobio.2007.04.002","article-title":"Adenosine A2A receptors in ventral striatum, hypothalamus and nociceptive circuitry implications for drug addiction, sleep and pain","volume":"83","author":"Ferre","year":"2007","journal-title":"Prog Neurobiol"},{"issue":"4","key":"10.1016\/j.pharmthera.2009.11.002_bib177","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1142\/S0219635205000987","article-title":"Role of adenosine in the control of homosynaptic plasticity in striatal excitatory synapses","volume":"4","author":"Ferre","year":"2005","journal-title":"J Integr Neurosci"},{"key":"10.1016\/j.pharmthera.2009.11.002_bib178","series-title":"The Mesolimbic Dopamine System: From Motivation to Action","article-title":"The dopamine hypothesis of schizophrenia and mood disorders: contradictions and speculations","author":"Fibeger","year":"1991"},{"issue":"1","key":"10.1016\/j.pharmthera.2009.11.002_bib179","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00213-006-0694-7","article-title":"Diverse effects of GABA-mimetic drugs on cocaine-evoked self-administration and discriminative stimulus effects in rats","volume":"192","author":"Filip","year":"2007","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pharmthera.2009.11.002_bib180","series-title":"Treating tobacco use and dependence: 2008 Update","author":"Fiore","year":"2008"},{"issue":"4","key":"10.1016\/j.pharmthera.2009.11.002_bib181","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1007\/s11524-007-9198-y","article-title":"Heroin-assisted treatment (HAT) a decade later: a brief update on science and politics","volume":"84","author":"Fischer","year":"2007","journal-title":"J Urban Health"},{"issue":"4","key":"10.1016\/j.pharmthera.2009.11.002_bib182","first-page":"576","article-title":"Differential effects of the 5-HT(2A) receptor antagonist M100907 and the 5-HT(2C) receptor antagonist SB242084 on cocaine-induced locomotor activity, cocaine self-administration and cocaine-induced reinstatement of responding","volume":"27","author":"Fletcher","year":"2002","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.pharmthera.2009.11.002_bib183","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1124\/jpet.104.072025","article-title":"Long-term ethanol self-administration by cynomolgus macaques alters the pharmacology and expression of GABAA receptors in basolateral amygdala","volume":"311","author":"Floyd","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"10.1016\/j.pharmthera.2009.11.002_bib184","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/S0026-895X(25)09036-4","article-title":"Interactions of cocaine with primary and secondary recognition sites on muscarinic receptors","volume":"41","author":"Flynn","year":"1992","journal-title":"Mol Pharmacol"},{"issue":"6","key":"10.1016\/j.pharmthera.2009.11.002_bib185","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1111\/j.1530-0277.1998.tb03897.x","article-title":"Modulation of volitional ethanol intake in the rat by central delta-opioid receptors","volume":"22","author":"Franck","year":"1998","journal-title":"Alcohol Clin Exp Res"},{"issue":"1\u20133","key":"10.1016\/j.pharmthera.2009.11.002_bib186","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ejphar.2008.09.018","article-title":"Neuroadaptive changes in the rat brain GABA(B) receptors after withdrawal from cocaine self-administration","volume":"599","author":"Frankowska","year":"2008","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"10.1016\/j.pharmthera.2009.11.002_bib187","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1530-0277.2001.tb02209.x","article-title":"Effects of SR141716A on ethanol and sucrose self-administration","volume":"25","author":"Freedland","year":"2001","journal-title":"Alcohol Clin Exp Res"},{"issue":"10","key":"10.1016\/j.pharmthera.2009.11.002_bib188","first-page":"1116","article-title":"Taranabant, a novel cannabinoid type 1 receptor inverse agonist","volume":"9","author":"Fremming","year":"2008","journal-title":"Curr Opin Investig Drugs"},{"issue":"11","key":"10.1016\/j.pharmthera.2009.11.002_bib189","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1111\/j.1360-0443.2006.01569.x","article-title":"A prospective cohort study on orally administered heroin substitution for severely addicted opioid users","volume":"101","author":"Frick","year":"2006","journal-title":"Addiction"},{"issue":"1","key":"10.1016\/j.pharmthera.2009.11.002_bib190","first-page":"29","article-title":"Effects of ifenprodil on the discriminative stimulus effects of cocaine in rhesus monkeys","volume":"27","author":"Fujiwara","year":"2007","journal-title":"Nihon Shinkei Seishin Yakurigaku Zasshi"},{"issue":"44","key":"10.1016\/j.pharmthera.2009.11.002_bib191","doi-asserted-by":"crossref","first-page":"11324","DOI":"10.1523\/JNEUROSCI.3096-06.2006","article-title":"Corticotropin-releasing factor within the central nucleus of the amygdala mediates enhanced ethanol self-administration in withdrawn, ethanol-dependent rats","volume":"26","author":"Funk","year":"2006","journal-title":"J Neurosci"},{"issue":"11","key":"10.1016\/j.pharmthera.2009.11.002_bib192","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.4088\/JCP.v68n1108","article-title":"Gabapentin reduces alcohol consumption and craving: a randomized, double-blind, placebo-controlled trial","volume":"68","author":"Furieri","year":"2007","journal-title":"J Clin Psychiatry"},{"issue":"3","key":"10.1016\/j.pharmthera.2009.11.002_bib193","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/BF02191883","article-title":"Clinical efficacy of gamma-hydroxybutyric acid in treatment of opiate withdrawal","volume":"244","author":"Gallimberti","year":"1994","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"issue":"6","key":"10.1016\/j.pharmthera.2009.11.002_bib194","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0740-5472(96)00154-7","article-title":"A controlled trial of imipramine for the treatment of methamphetamine dependence","volume":"13","author":"Galloway","year":"1996","journal-title":"J Subst Abuse Treat"},{"issue":"5","key":"10.1016\/j.pharmthera.2009.11.002_bib195","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.neuropharm.2006.06.009","article-title":"A slow-onset, long-duration indanamine monoamine reuptake inhibitor as a potential maintenance pharmacotherapy for psychostimulant abuse: effects in laboratory rat models relating to addiction","volume":"51","author":"Gardner","year":"2006","journal-title":"Neuropharmacology"},{"issue":"4","key":"10.1016\/j.pharmthera.2009.11.002_bib196","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/npp.2008.140","article-title":"mGluR5 antagonism attenuates methamphetamine reinforcement and prevents reinstatement of methamphetamine-seeking behavior in rats","volume":"34","author":"Gass","year":"2009","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.pharmthera.2009.11.002_bib197","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/01.fbp.0000197459.08892.b5","article-title":"Effects of monoamine oxidase inhibitors on cocaine discrimination in rats","volume":"17","author":"Gatch","year":"2006","journal-title":"Behav Pharmacol"},{"issue":"3","key":"10.1016\/j.pharmthera.2009.11.002_bib198","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1001\/archpsyc.1989.01810030094013","article-title":"Buspirone reduces smoking","volume":"46","author":"Gawin","year":"1989","journal-title":"Arch Gen Psychiatry"},{"issue":"9","key":"10.1016\/j.pharmthera.2009.11.002_bib199","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1001\/archpsyc.1984.01790200085011","article-title":"Cocaine abuse treatment. Open pilot trial with desipramine and lithium carbonate","volume":"41","author":"Gawin","year":"1984","journal-title":"Arch Gen Psychiatry"},{"issue":"2","key":"10.1016\/j.pharmthera.2009.11.002_bib200","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1001\/archpsyc.1989.01810020019004","article-title":"Desipramine facilitation of initial cocaine abstinence","volume":"46","author":"Gawin","year":"1989","journal-title":"Arch Gen Psychiatry"},{"issue":"10","key":"10.1016\/j.pharmthera.2009.11.002_bib201","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.1523\/JNEUROSCI.4985-06.2007","article-title":"3-(4-Chloro-2-morpholin-4-yl-thiazol-5-yl)-8-(1-ethylpropyl)-2, 6-dimethyl- imidazo[1, 2-b]pyridazine: a novel brain-penetrant, orally available corticotropin-releasing factor receptor 1 antagonist with efficacy in animal models of alcoholism","volume":"27","author":"Gehlert","year":"2007","journal-title":"J Neurosci"},{"issue":"6","key":"10.1016\/j.pharmthera.2009.11.002_bib202","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.intimp.2006.01.008","article-title":"Safety and efficiency of an anti-(+)-methamphetamine monoclonal antibody in the protection against cardiovascular and central nervous system effects of (+)-methamphetamine in rats","volume":"6","author":"Gentry","year":"2006","journal-title":"Int Immunopharmacol"},{"issue":"5869","key":"10.1016\/j.pharmthera.2009.11.002_bib203","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1126\/science.1153813","article-title":"Neurokinin 1 receptor antagonism as a possible therapy for alcoholism","volume":"319","author":"George","year":"2008","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.pharmthera.2009.11.002_bib204","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S0006-3223(02)01454-3","article-title":"A preliminary placebo-controlled trial of selegiline hydrochloride for smoking cessation","volume":"53","author":"George","year":"2003","journal-title":"Biol Psychiatry"},{"issue":"6","key":"10.1016\/j.pharmthera.2009.11.002_bib205","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/0740-5472(93)90055-7","article-title":"Behavioral response to buspirone in cocaine and phencyclidine withdrawal","volume":"10","author":"Giannini","year":"1993","journal-title":"J Subst Abuse Treat"},{"issue":"1","key":"10.1016\/j.pharmthera.2009.11.002_bib206","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/syn.20152","article-title":"Acute administration of SB-277011A, NGB 2904, or BP 897 inhibits cocaine cue-induced reinstatement of drug-seeking behavior in rats: role of dopamine D3 receptors","volume":"57","author":"Gilbert","year":"2005","journal-title":"Synapse"},{"issue":"1\u20133","key":"10.1016\/j.pharmthera.2009.11.002_bib207","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2004.01.036","article-title":"Contributions of 5-HT(2C) receptors to multiple actions of central serotonin systems","volume":"488","author":"Giorgetti","year":"2004","journal-title":"Eur J Pharmacol"},{"issue":"1\u20133","key":"10.1016\/j.pharmthera.2009.11.002_bib208","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ejphar.2006.03.045","article-title":"18-Methoxycoronaridine acts in the medial habenula and\/or interpeduncular nucleus to decrease morphine self-administration in rats","volume":"537","author":"Glick","year":"2006","journal-title":"Eur J Pharmacol"},{"issue":"5","key":"10.1016\/j.pharmthera.2009.11.002_bib209","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1111\/j.1360-0443.2007.01763.x","article-title":"A randomized, controlled trial to assess the efficacy and safety of a transdermal delivery system of nicotine\/mecamylamine in cigarette smokers","volume":"102","author":"Glover","year":"2007","journal-title":"Addiction"},{"issue":"3","key":"10.1016\/j.pharmthera.2009.11.002_bib210","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1037\/1064-1297.3.3.219","article-title":"Effects of dopamine reuptake inhibitors on food- and cocaine-maintained responding: I. Dependence on unit dose of cocaine","volume":"3","author":"Glowa","year":"1995","journal-title":"Exp Clin Psychopharmacol"},{"issue":"3","key":"10.1016\/j.pharmthera.2009.11.002_bib211","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s00213-002-1007-4","article-title":"Potential role for the hypothalamo-pituitary-adrenal axis in the conditioned reinforcer-induced reinstatement of extinguished cocaine seeking in rats","volume":"161","author":"Goeders","year":"2002","journal-title":"Psychopharmacology (Berl)"},{"issue":"7","key":"10.1016\/j.pharmthera.2009.11.002_bib212","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nrg1635","article-title":"The genetics of addictions: uncovering the genes","volume":"6","author":"Goldman","year":"2005","journal-title":"Nat Rev Genet"},{"issue":"1","key":"10.1016\/j.pharmthera.2009.11.002_bib213","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0006-8993(02)03344-9","article-title":"Changes in endocannabinoid contents in the brain of rats chronically exposed to nicotine, ethanol or cocaine","volume":"954","author":"Gonzalez","year":"2002","journal-title":"Brain Res"},{"issue":"4","key":"10.1016\/j.pharmthera.2009.11.002_bib214","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1176\/appi.ajp.158.4.540","article-title":"Cognitive function and cerebral perfusion during cocaine abstinence","volume":"158","author":"Gottschalk","year":"2001","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pharmthera.2009.11.002_bib215","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD000058.pub2","article-title":"Clonidine for smoking cessation","volume":"3","author":"Gourlay","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.pharmthera.2009.11.002_bib216","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002021","article-title":"Opioid antagonists with minimal sedation for opioid withdrawal","volume":"2","author":"Gowing","year":"2002","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.pharmthera.2009.11.002_bib217","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/00004714-199506000-00004","article-title":"Fluoxetine is ineffective for treatment of cocaine dependence or concurrent opiate and cocaine dependence: two placebo-controlled double-blind trials","volume":"15","author":"Grabowski","year":"1995","journal-title":"J Clin Psychopharmacol"},{"issue":"5","key":"10.1016\/j.pharmthera.2009.11.002_bib218","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1097\/00004714-200110000-00010","article-title":"Dextroamphetamine for cocaine-dependence treatment: a double-blind randomized clinical trial","volume":"21","author":"Grabowski","year":"2001","journal-title":"J Clin Psychopharmacol"},{"issue":"2","key":"10.1016\/j.pharmthera.2009.11.002_bib219","doi-asserted-by":"crossref","first-page":"103","DOI":"10.5694\/j.1326-5377.2002.tb04683.x","article-title":"New pharmacotherapies for alcohol dependence","volume":"177","author":"Graham","year":"2002","journal-title":"Med J Aust"},{"issue":"2","key":"10.1016\/j.pharmthera.2009.11.002_bib220","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.phrs.2006.11.005","article-title":"Short-term efficacy of Disulfiram or Naltrexone in reducing positive urinalysis for both cocaine and cocaethylene in cocaine abusers: a pilot study","volume":"55","author":"Grassi","year":"2007","journal-title":"Pharmacol Res"},{"issue":"3","key":"10.1016\/j.pharmthera.2009.11.002_bib221","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.pbb.2008.07.012","article-title":"The alpha(1) adrenergic receptor antagonist prazosin reduces heroin self-administration in rats with extended access to heroin administration","volume":"91","author":"Greenwell","year":"2009","journal-title":"Pharmacol Biochem Behav"},{"issue":"9","key":"10.1016\/j.pharmthera.2009.11.002_bib222","doi-asserted-by":"crossref","first-page":"6370","DOI":"10.1073\/pnas.092012099","article-title":"Anxiolytic- and antidepressant-like effects of the non-peptide vasopressin V1b receptor antagonist, SSR149415, suggest an innovative approach for the treatment of stress-related disorders","volume":"99","author":"Griebel","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1016\/j.pharmthera.2009.11.002_bib223","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1007\/s002130100801","article-title":"Activation of 5-HT(2C) receptors reduces the locomotor and rewarding effects of nicotine","volume":"157","author":"Grottick","year":"2001","journal-title":"Psychopharmacology (Berl)"},{"issue":"1","key":"10.1016\/j.pharmthera.2009.11.002_bib224","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2217\/14622416.7.1.31","article-title":"Pharmacogenomics: a path to predictive medicine for schizophrenia","volume":"7","author":"Gupta","year":"2006","journal-title":"Pharmacogenomics"},{"issue":"3","key":"10.1016\/j.pharmthera.2009.11.002_bib225","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1124\/jpet.106.107920","article-title":"Effects of RGH-237 [N-{4-[4-(3-aminocarbonyl-phenyl)-piperazin-1-yl]-butyl}-4-bromo-benzamide ], an orally active, selective dopamine D(3) receptor partial agonist in animal models of cocaine abuse","volume":"320","author":"Gyertyan","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"10.1016\/j.pharmthera.2009.11.002_bib226","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1080\/00952990802122564","article-title":"Pharmacogenetic treatments for drug addiction: alcohol and opiates","volume":"34","author":"Haile","year":"2008","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"8638","key":"10.1016\/j.pharmthera.2009.11.002_bib227","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0140-6736(89)91660-7","article-title":"Carbamazepine for cocaine addiction?","volume":"1","author":"Halikas","year":"1989","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.pharmthera.2009.11.002_bib228","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0009-9236(97)90155-7","article-title":"A randomized double-blind study of carbamazepine in the treatment of cocaine abuse","volume":"62","author":"Halikas","year":"1997","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.pharmthera.2009.11.002_bib229","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3109\/00952999209001610","article-title":"Treatment of crack cocaine use with carbamazepine","volume":"18","author":"Halikas","year":"1992","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"1","key":"10.1016\/j.pharmthera.2009.11.002_bib230","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/clpt.1991.107","article-title":"Cocaine reduction in unmotivated crack users using carbamazepine versus placebo in a short-term, double-blind crossover design","volume":"50","author":"Halikas","year":"1991","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.pharmthera.2009.11.002_bib231","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.neuroscience.2007.01.063","article-title":"The neural correlates and role of D1 dopamine receptors in renewal of extinguished alcohol-seeking","volume":"146","author":"Hamlin","year":"2007","journal-title":"Neuroscience"},{"issue":"3","key":"10.1016\/j.pharmthera.2009.11.002_bib232","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s00213-008-1079-x","article-title":"Controversies in translational research: drug self-administration","volume":"199","author":"Haney","year":"2008","journal-title":"Psychopharmacology (Berl)"},{"issue":"8","key":"10.1016\/j.pharmthera.2009.11.002_bib233","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1038\/sj.npp.1300999","article-title":"Effects of baclofen on cocaine self-administration: opioid- and nonopioid-dependent volunteers","volume":"31","author":"Haney","year":"2006","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.pharmthera.2009.11.002_bib234","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s00213-002-1210-3","article-title":"Nefazodone decreases anxiety during marijuana withdrawal in humans","volume":"165","author":"Haney","year":"2003","journal-title":"Psychopharmacology (Berl)"},{"issue":"2","key":"10.1016\/j.pharmthera.2009.11.002_bib235","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s002130000657","article-title":"Bupropion SR worsens mood during marijuana withdrawal in humans","volume":"155","author":"Haney","year":"2001","journal-title":"Psychopharmacology (Berl)"},{"issue":"1","key":"10.1016\/j.pharmthera.2009.11.002_bib236","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s00213-007-1020-8","article-title":"Effects of THC and lofexidine in a human laboratory model of marijuana withdrawal and relapse","volume":"197","author":"Haney","year":"2008","journal-title":"Psychopharmacology (Berl)"},{"issue":"1","key":"10.1016\/j.pharmthera.2009.11.002_bib237","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/sj.npp.1300310","article-title":"Marijuana withdrawal in humans: effects of oral THC or divalproex","volume":"29","author":"Haney","year":"2004","journal-title":"Neuropsychopharmacology"},{"issue":"7","key":"10.1016\/j.pharmthera.2009.11.002_bib238","doi-asserted-by":"crossref","first-page":"611","DOI":"10.2146\/ajhp070112","article-title":"Quetiapine: treatment for substance abuse and drug of abuse","volume":"65","author":"Hanley","year":"2008","journal-title":"Am J Health Syst Pharm"},{"issue":"1","key":"10.1016\/j.pharmthera.2009.11.002_bib239","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0091-3057(90)90236-B","article-title":"Reduction in oral ethanol self-administration in the rat by the 5-HT uptake blocker fluoxetine","volume":"35","author":"Haraguchi","year":"1990","journal-title":"Pharmacol Biochem Behav"},{"issue":"6493","key":"10.1016\/j.pharmthera.2009.11.002_bib240","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/371155a0","article-title":"Involvement of D2 dopamine receptors in the nucleus accumbens in the opiate withdrawal syndrome","volume":"371","author":"Harris","year":"1994","journal-title":"Nature"},{"issue":"7058","key":"10.1016\/j.pharmthera.2009.11.002_bib241","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/nature04071","article-title":"A role for lateral hypothalamic orexin neurons in reward seeking","volume":"437","author":"Harris","year":"2005","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.pharmthera.2009.11.002_bib242","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0893-133X(00)00237-2","article-title":"Fluoxetine combined with a serotonin-1A receptor antagonist reversed reward deficits observed during nicotine and amphetamine withdrawal in rats","volume":"25","author":"Harrison","year":"2001","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.pharmthera.2009.11.002_bib243","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s002139900363","article-title":"Comparison of intravenous cocaethylene and cocaine in humans","volume":"149","author":"Hart","year":"2000","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pharmthera.2009.11.002_bib244","series-title":"Faces and voices of recovery: Hart Research and Coldwater Corporation","author":"Hart","year":"2004"},{"key":"10.1016\/j.pharmthera.2009.11.002_bib245","series-title":"Updating estimates of the economic cost of alcohol abuse in the United States: Estimates, update methods, and data report. The Lewin Group for the National Institute on Alcohol Abuse and Alcoholism","author":"Harwood","year":"2000"},{"issue":"4","key":"10.1016\/j.pharmthera.2009.11.002_bib246","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1001\/archpsyc.59.4.375","article-title":"Effects of major depression on remission and relapse of substance dependence","volume":"59","author":"Hasin","year":"2002","journal-title":"Arch Gen Psychiatry"},{"issue":"10","key":"10.1016\/j.pharmthera.2009.11.002_bib247","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1111\/j.1360-0443.2008.02292.x","article-title":"Marijuana withdrawal and craving: influence of the cannabinoid receptor 1 (CNR1) and fatty acid amide hydrolase (FAAH) genes","volume":"103","author":"Haughey","year":"2008","journal-title":"Addiction"},{"issue":"2","key":"10.1016\/j.pharmthera.2009.11.002_bib248","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.bbr.2008.08.034","article-title":"Differential effects of 5-HT2C receptor activation by WAY 161503 on nicotine-induced place conditioning and locomotor activity in rats","volume":"197","author":"Hayes","year":"2009","journal-title":"Behav Brain Res"},{"issue":"3","key":"10.1016\/j.pharmthera.2009.11.002_bib249","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1523\/JNEUROSCI.3959-04.2005","article-title":"Glial cell line-derived neurotrophic factor mediates the desirable actions of the anti-addiction drug ibogaine against alcohol consumption","volume":"25","author":"He","year":"2005","journal-title":"J Neurosci"},{"issue":"1","key":"10.1016\/j.pharmthera.2009.11.002_bib250","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1369-1600.2007.00051.x","article-title":"Evidence for the role of dopamine D3 receptors in oral operant alcohol self-administration and reinstatement of alcohol-seeking behavior in mice","volume":"12","author":"Heidbreder","year":"2007","journal-title":"Addict Biol"},{"issue":"3","key":"10.1016\/j.pharmthera.2009.11.002_bib251","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.pharmthera.2006.02.001","article-title":"Pharmacological treatment of alcohol dependence: target symptoms and target mechanisms","volume":"111","author":"Heilig","year":"2006","journal-title":"Pharmacol Ther"},{"issue":"8","key":"10.1016\/j.pharmthera.2009.11.002_bib252","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.tins.2007.06.006","article-title":"A key role for corticotropin-releasing factor in alcohol dependence","volume":"30","author":"Heilig","year":"2007","journal-title":"Trends Neurosci"},{"issue":"4","key":"10.1016\/j.pharmthera.2009.11.002_bib253","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/npp.1993.35","article-title":"Anxiolytic-like action of neuropeptide Y: mediation by Y1 receptors in amygdala, and dissociation from food intake effects","volume":"8","author":"Heilig","year":"1993","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.pharmthera.2009.11.002_bib254","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.drugalcdep.2006.03.019","article-title":"Randomized, placebo-controlled trial of baclofen and gabapentin for the treatment of methamphetamine dependence","volume":"85","author":"Heinzerling","year":"2006","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.pharmthera.2009.11.002_bib255","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1242\/jeb.196.1.251","article-title":"Biochemistry and molecular biology of the vesicular monoamine transporter from chromaffin granules","volume":"196","author":"Henry","year":"1994","journal-title":"J Exp Biol"},{"issue":"Pt 3","key":"10.1016\/j.pharmthera.2009.11.002_bib256","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1042\/0264-6021:3590465","article-title":"Structural, signalling and regulatory properties of the group I metabotropic glutamate receptors: prototypic family C G-protein-coupled receptors","volume":"359","author":"Hermans","year":"2001","journal-title":"Biochem J"},{"issue":"7","key":"10.1016\/j.pharmthera.2009.11.002_bib257","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.neuropharm.2004.07.037","article-title":"Effects of MPEP on locomotion, sensitization and conditioned reward induced by cocaine or morphine","volume":"47","author":"Herzig","year":"2004","journal-title":"Neuropharmacology"},{"issue":"3","key":"10.1016\/j.pharmthera.2009.11.002_bib258","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0024-3205(94)00878-7","article-title":"Influence of an alternative reinforcer on human cocaine self-administration","volume":"55","author":"Higgins","year":"1994","journal-title":"Life Sci"},{"issue":"10","key":"10.1016\/j.pharmthera.2009.11.002_bib259","doi-asserted-by":"crossref","first-page":"851","DOI":"10.2165\/00023210-200721100-00005","article-title":"Biological treatments for amfetamine dependence: recent progress","volume":"21","author":"Hill","year":"2007","journal-title":"CNS Drugs"},{"issue":"2","key":"10.1016\/j.pharmthera.2009.11.002_bib260","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1001\/archinte.152.2.350","article-title":"Effect of buspirone on withdrawal symptoms associated with smoking cessation","volume":"152","author":"Hilleman","year":"1992","journal-title":"Arch Intern Med"},{"issue":"11","key":"10.1016\/j.pharmthera.2009.11.002_bib261","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.tips.2003.09.011","article-title":"Neuropeptide systems as novel therapeutic targets for depression and anxiety disorders","volume":"24","author":"Holmes","year":"2003","journal-title":"Trends Pharmacol Sci"},{"issue":"4","key":"10.1016\/j.pharmthera.2009.11.002_bib262","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1111\/j.1471-4159.2008.05534.x","article-title":"Long-term administration of cocaine or serotonin reuptake inhibitors results in anatomical and neurochemical changes in noradrenergic, dopaminergic, and serotonin pathways","volume":"106","author":"Horne","year":"2008","journal-title":"J Neurochem"},{"issue":"2","key":"10.1016\/j.pharmthera.2009.11.002_bib263","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s00213-002-1152-9","article-title":"Effects of selegiline (l-deprenyl) during smoking and short-term abstinence","volume":"163","author":"Houtsmuller","year":"2002","journal-title":"Psychopharmacology (Berl)"},{"issue":"4","key":"10.1016\/j.pharmthera.2009.11.002_bib264","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1080\/14622200500185298","article-title":"Nortriptyline for smoking cessation: a review","volume":"7","author":"Hughes","year":"2005","journal-title":"Nicotine Tob Res"},{"key":"10.1016\/j.pharmthera.2009.11.002_bib265","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD000031.pub3","article-title":"Antidepressants for smoking cessation","volume":"1","author":"Hughes","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.pharmthera.2009.11.002_bib266","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.neuroscience.2004.01.025","article-title":"Genetic and pharmacological manipulation of mu opioid receptors in mice reveals a differential effect on behavioral sensitization to cocaine","volume":"125","author":"Hummel","year":"2004","journal-title":"Neuroscience"},{"issue":"4","key":"10.1016\/j.pharmthera.2009.11.002_bib267","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1046\/j.1471-4159.2003.01576.x","article-title":"Cannabinoid CB1 receptor knockout mice exhibit markedly reduced voluntary alcohol consumption and lack alcohol-induced dopamine release in the nucleus accumbens","volume":"84","author":"Hungund","year":"2003","journal-title":"J Neurochem"},{"issue":"17","key":"10.1016\/j.pharmthera.2009.11.002_bib268","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1056\/NEJM199710233371703","article-title":"A comparison of sustained-release bupropion and placebo for smoking cessation","volume":"337","author":"Hurt","year":"1997","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.pharmthera.2009.11.002_bib269","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.bbi.2008.09.012","article-title":"Reduction of opioid withdrawal and potentiation of acute opioid analgesia by systemic AV411 (ibudilast)","volume":"23","author":"Hutchinson","year":"2009","journal-title":"Brain Behav Immun"},{"issue":"1","key":"10.1016\/j.pharmthera.2009.11.002_bib270","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s002130000629","article-title":"Olanzapine reduces urge to drink after drinking cues and a priming dose of alcohol","volume":"155","author":"Hutchison","year":"2001","journal-title":"Psychopharmacology (Berl)"},{"issue":"1\u20133","key":"10.1016\/j.pharmthera.2009.11.002_bib271","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0014-2999(95)00314-B","article-title":"GABAA receptor antagonism in the extended amygdala decreases ethanol self-administration in rats","volume":"283","author":"Hyytia","year":"1995","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"10.1016\/j.pharmthera.2009.11.002_bib272","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1021\/jm050570f","article-title":"Synthesis and structure\u2013activity relationships of 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine analogues as potent, noncompetitive metabotropic glutamate receptor subtype 5 antagonists; search for cocaine medications","volume":"49","author":"Iso","year":"2006","journal-title":"J Med Chem"},{"issue":"6","key":"10.1016\/j.pharmthera.2009.11.002_bib273","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1097\/01.jcp.0000144893.29987.e5","article-title":"Effects of naltrexone on the subjective response to amphetamine in healthy volunteers","volume":"24","author":"Jayaram-Lindstrom","year":"2004","journal-title":"J Clin Psychopharmacol"},{"issue":"3","key":"10.1016\/j.pharmthera.2009.11.002_bib274","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1080\/08039480510023052","article-title":"An open clinical trial of naltrexone for amphetamine dependence: compliance and tolerability","volume":"59","author":"Jayaram-Lindstrom","year":"2005","journal-title":"Nord J Psychiatry"},{"issue":"11","key":"10.1016\/j.pharmthera.2009.11.002_bib275","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1176\/appi.ajp.2008.08020304","article-title":"Naltrexone for the treatment of amphetamine dependence: a randomized, placebo-controlled trial","volume":"165","author":"Jayaram-Lindstrom","year":"2008","journal-title":"Am J Psychiatry"},{"issue":"8","key":"10.1016\/j.pharmthera.2009.11.002_bib276","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1038\/sj.npp.1301572","article-title":"Naltrexone attenuates the subjective effects of amphetamine in patients with amphetamine dependence","volume":"33","author":"Jayaram-Lindstrom","year":"2008","journal-title":"Neuropsychopharmacology"},{"issue":"5","key":"10.1016\/j.pharmthera.2009.11.002_bib277","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1523\/JNEUROSCI.3786-05.2006","article-title":"The dopamine D3 receptor is part of a homeostatic pathway regulating ethanol consumption","volume":"26","author":"Jeanblanc","year":"2006","journal-title":"J Neurosci"},{"issue":"1","key":"10.1016\/j.pharmthera.2009.11.002_bib278","first-page":"21","article-title":"A pilot trial of gepirone vs. placebo in the treatment of cocaine dependency","volume":"28","author":"Jenkins","year":"1992","journal-title":"Psychopharmacol Bull"},{"issue":"1","key":"10.1016\/j.pharmthera.2009.11.002_bib279","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S0304-3940(00)01188-5","article-title":"Dual effects of dextromethorphan on cocaine-induced conditioned place preference in mice","volume":"288","author":"Jhoo","year":"2000","journal-title":"Neurosci Lett"},{"issue":"3","key":"10.1016\/j.pharmthera.2009.11.002_bib280","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/nm1349","article-title":"Disruption of PTEN coupling with 5-HT2C receptors suppresses behavioral responses induced by drugs of abuse","volume":"12","author":"Ji","year":"2006","journal-title":"Nat Med"},{"issue":"24","key":"10.1016\/j.pharmthera.2009.11.002_bib281","doi-asserted-by":"crossref","first-page":"8048","DOI":"10.1021\/jm801162z","article-title":"Development of 3-phenyltropane analogues with high affinity for the dopamine and serotonin transporters and low affinity for the norepinephrine transporter","volume":"51","author":"Jin","year":"2008","journal-title":"J Med Chem"},{"issue":"5","key":"10.1016\/j.pharmthera.2009.11.002_bib282","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1586\/14737175.4.5.751","article-title":"Uses of topiramate in the treatment of alcohol dependence","volume":"4","author":"Johnson","year":"2004","journal-title":"Expert Rev Neurother"},{"issue":"1","key":"10.1016\/j.pharmthera.2009.11.002_bib283","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.bcp.2007.08.005","article-title":"Update on neuropharmacological treatments for alcoholism: scientific basis and clinical findings","volume":"75","author":"Johnson","year":"2008","journal-title":"Biochem Pharmacol"},{"issue":"10","key":"10.1016\/j.pharmthera.2009.11.002_bib284","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/S0006-3223(96)00490-8","article-title":"Ritanserin in the treatment of cocaine dependence","volume":"42","author":"Johnson","year":"1997","journal-title":"Biol Psychiatry"},{"issue":"9370","key":"10.1016\/j.pharmthera.2009.11.002_bib285","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/S0140-6736(03)13370-3","article-title":"Oral topiramate for treatment of alcohol dependence: a randomised controlled trial","volume":"361","author":"Johnson","year":"2003","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.pharmthera.2009.11.002_bib286","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1461145707007778","article-title":"A preliminary randomized, double-blind, placebo-controlled study of the safety and efficacy of ondansetron in the treatment of methamphetamine dependence","volume":"11","author":"Johnson","year":"2008","journal-title":"Int J Neuropsychopharmacol"},{"issue":"3","key":"10.1016\/j.pharmthera.2009.11.002_bib287","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.drugalcdep.2006.02.011","article-title":"A preliminary randomized, double-blind, placebo-controlled study of the safety and efficacy of ondansetron in the treatment of cocaine dependence","volume":"84","author":"Johnson","year":"2006","journal-title":"Drug Alcohol Depend"},{"issue":"14","key":"10.1016\/j.pharmthera.2009.11.002_bib288","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1001\/jama.298.14.1641","article-title":"Topiramate for treating alcohol dependence: a randomized controlled trial","volume":"298","author":"Johnson","year":"2007","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.pharmthera.2009.11.002_bib289","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1038\/nrd2775","article-title":"End of the line for cannabinoid receptor 1 as an anti-obesity target?","volume":"7","author":"Jones","year":"2008","journal-title":"Nat Rev Drug Discov"},{"issue":"5","key":"10.1016\/j.pharmthera.2009.11.002_bib290","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1080\/10550490490512753","article-title":"Safety and efficacy of l-tryptophan and behavioral incentives for treatment of cocaine dependence: a randomized clinical trial","volume":"13","author":"Jones","year":"2004","journal-title":"Am J Addict"},{"issue":"50","key":"10.1016\/j.pharmthera.2009.11.002_bib291","doi-asserted-by":"crossref","first-page":"11244","DOI":"10.1523\/JNEUROSCI.3009-04.2004","article-title":"Precise localization of alpha7 nicotinic acetylcholine receptors on glutamatergic axon terminals in the rat ventral tegmental area","volume":"24","author":"Jones","year":"2004","journal-title":"J Neurosci"},{"issue":"Suppl 2","key":"10.1016\/j.pharmthera.2009.11.002_bib292","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2165\/00003495-200262002-00003","article-title":"Clinical efficacy of bupropion in the management of smoking cessation","volume":"62","author":"Jorenby","year":"2002","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.pharmthera.2009.11.002_bib293","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s002130051145","article-title":"The delta 2-opioid receptor antagonist naltriben reduces motivated responding for ethanol","volume":"147","author":"June","year":"1999","journal-title":"Psychopharmacology (Berl)"},{"issue":"8","key":"10.1016\/j.pharmthera.2009.11.002_bib294","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nrn2515","article-title":"The glutamate homeostasis hypothesis of addiction","volume":"10","author":"Kalivas","year":"2009","journal-title":"Nat Rev Neurosci"},{"issue":"4","key":"10.1016\/j.pharmthera.2009.11.002_bib295","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1046\/j.1471-4159.1998.70041497.x","article-title":"Repeated cocaine administration alters extracellular glutamate in the ventral tegmental area","volume":"70","author":"Kalivas","year":"1998","journal-title":"J Neurochem"},{"issue":"3","key":"10.1016\/j.pharmthera.2009.11.002_bib296","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0306-4603(02)00226-5","article-title":"A pilot trial of piracetam and ginkgo biloba for the treatment of cocaine dependence","volume":"28","author":"Kampman","year":"2003","journal-title":"Addict Behav"},{"issue":"2","key":"10.1016\/j.pharmthera.2009.11.002_bib297","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1151\/ascp084228","article-title":"The search for medications to treat stimulant dependence","volume":"4","author":"Kampman","year":"2008","journal-title":"Addict Sci Clin Pract"},{"issue":"3","key":"10.1016\/j.pharmthera.2009.11.002_bib298","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.drugalcdep.2004.03.008","article-title":"A pilot trial of topiramate for the treatment of cocaine dependence","volume":"75","author":"Kampman","year":"2004","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"10.1016\/j.pharmthera.2009.11.002_bib299","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.drugalcdep.2006.04.002","article-title":"A double-blind, placebo-controlled trial of amantadine, propranolol, and their combination for the treatment of cocaine dependence in patients with severe cocaine withdrawal symptoms","volume":"85","author":"Kampman","year":"2006","journal-title":"Drug Alcohol Depend"},{"issue":"6\u20137","key":"10.1016\/j.pharmthera.2009.11.002_bib300","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.addbeh.2009.03.014","article-title":"Initiating acamprosate within-detoxification versus post-detoxification in the treatment of alcohol dependence","volume":"34","author":"Kampman","year":"2009","journal-title":"Addict Behav"},{"issue":"4","key":"10.1016\/j.pharmthera.2009.11.002_bib301","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/JCP.0b013e3180ca86e5","article-title":"A double-blind, placebo-controlled pilot trial of quetiapine for the treatment of Type A and Type B alcoholism","volume":"27","author":"Kampman","year":"2007","journal-title":"J Clin Psychopharmacol"},{"issue":"1","key":"10.1016\/j.pharmthera.2009.11.002_bib302","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0376-8716(00)00193-9","article-title":"Effectiveness of propranolol for cocaine dependence treatment may depend on cocaine withdrawal symptom severity","volume":"63","author":"Kampman","year":"2001","journal-title":"Drug Alcohol Depend"},{"issue":"5","key":"10.1016\/j.pharmthera.2009.11.002_bib303","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1111\/j.1460-9568.2005.03945.x","article-title":"Regulation of Homer and group I metabotropic glutamate receptors by nicotine","volume":"21","author":"Kane","year":"2005","journal-title":"Eur J Neurosci"},{"issue":"5","key":"10.1016\/j.pharmthera.2009.11.002_bib304","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1080\/00952990802183921","article-title":"Mirtazapine, a noradrenergic and specific serotonergic antidepressant, attenuates morphine dependence and withdrawal in Sprague\u2013Dawley rats","volume":"34","author":"Kang","year":"2008","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"3","key":"10.1016\/j.pharmthera.2009.11.002_bib305","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s002130050049","article-title":"Evaluation of anti-cocaine antibodies and a cocaine vaccine in a rat self-administration model","volume":"148","author":"Kantak","year":"2000","journal-title":"Psychopharmacology (Berl)"},{"issue":"7","key":"10.1016\/j.pharmthera.2009.11.002_bib306","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1111\/j.1530-0277.2007.00401.x","article-title":"Targeted nalmefene with simple medical management in the treatment of heavy drinkers: a randomized double-blind placebo-controlled multicenter study","volume":"31","author":"Karhuvaara","year":"2007","journal-title":"Alcohol Clin Exp Res"},{"issue":"3","key":"10.1016\/j.pharmthera.2009.11.002_bib307","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1017\/S1461145707008097","article-title":"New treatments for cocaine dependence: a focused review","volume":"11","author":"Karila","year":"2008","journal-title":"Int J Neuropsychopharmacol"},{"issue":"3","key":"10.1016\/j.pharmthera.2009.11.002_bib308","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1254\/jphs.FMJ04007X3","article-title":"Functional proteins involved in regulation of intracellular Ca(2+) for drug development: chronic nicotine treatment upregulates L-type high voltage-gated calcium channels","volume":"97","author":"Katsura","year":"2005","journal-title":"J Pharmacol Sci"},{"issue":"2","key":"10.1016\/j.pharmthera.2009.11.002_bib310","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/JCP.0b013e318166f50d","article-title":"Quetiapine for the treatment of cocaine dependence: an open-label trial","volume":"28","author":"Kennedy","year":"2008","journal-title":"J Clin Psychopharmacol"},{"issue":"1","key":"10.1016\/j.pharmthera.2009.11.002_bib311","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00213-004-2069-2","article-title":"Metabotropic glutamate 5 receptor blockade may attenuate cocaine self-administration by decreasing brain reward function in rats","volume":"179","author":"Kenny","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"issue":"2","key":"10.1016\/j.pharmthera.2009.11.002_bib312","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/npp.2008.58","article-title":"NMDA receptors regulate nicotine-enhanced brain reward function and intravenous nicotine self-administration: role of the ventral tegmental area and central nucleus of the amygdala","volume":"34","author":"Kenny","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2009.11.002_bib313","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1196\/annals.1300.040","article-title":"Metabotropic glutamate 5 receptor antagonist MPEP decreased nicotine and cocaine self-administration but not nicotine and cocaine-induced facilitation of brain reward function in rats","volume":"1003","author":"Kenny","year":"2003","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"10.1016\/j.pharmthera.2009.11.002_bib314","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.drugalcdep.2005.05.002","article-title":"Factors associated with methadone maintenance therapy use among a cohort of polysubstance using injection drug users in Vancouver","volume":"80","author":"Kerr","year":"2005","journal-title":"Drug Alcohol Depend"},{"issue":"4","key":"10.1016\/j.pharmthera.2009.11.002_bib646","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/(SICI)1098-2396(199812)30:4<393::AID-SYN6>3.0.CO;2-H","article-title":"Reduced glutamate immunolabeling in the nucleus accumbens following extended withdrawal from self-administered cocaine","volume":"30","author":"Keys","year":"1998","journal-title":"Synapse"},{"issue":"9","key":"10.1016\/j.pharmthera.2009.11.002_bib315","first-page":"627","article-title":"Dextromethorphan alters the reinforcing effect of cocaine in the rat","volume":"19","author":"Kim","year":"1997","journal-title":"Methods Find Exp Clin Pharmacol"},{"issue":"1","key":"10.1016\/j.pharmthera.2009.11.002_bib316","doi-asserted-by":"crossref","first-page":"96","DOI":"10.15288\/jsa.1977.38.96","article-title":"The disulfiram-alcohol reaction: a review","volume":"38","author":"Kitson","year":"1977","journal-title":"J Stud Alcohol Drugs"},{"issue":"3","key":"10.1016\/j.pharmthera.2009.11.002_bib317","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/S0022-3565(24)39007-X","article-title":"Opioid receptor imaging with positron emission tomography and [(18)F]cyclofoxy in long-term, methadone-treated former heroin addicts","volume":"295","author":"Kling","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"issue":"5","key":"10.1016\/j.pharmthera.2009.11.002_bib318","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/01.yic.0000166815.83017.d8","article-title":"Mirtazapine in amphetamine detoxification: a placebo-controlled pilot study","volume":"20","author":"Kongsakon","year":"2005","journal-title":"Int Clin Psychopharmacol"},{"issue":"5335","key":"10.1016\/j.pharmthera.2009.11.002_bib319","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1126\/science.278.5335.52","article-title":"Drug abuse: hedonic homeostatic dysregulation","volume":"278","author":"Koob","year":"1997","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.pharmthera.2009.11.002_bib320","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1038\/nn1105-1442","article-title":"Plasticity of reward neurocircuitry and the \u2018dark side\u2019 of drug addiction","volume":"8","author":"Koob","year":"2005","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.pharmthera.2009.11.002_bib321","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1146\/annurev.psych.59.103006.093548","article-title":"Addiction and the brain antireward system","volume":"59","author":"Koob","year":"2008","journal-title":"Annu Rev Psychol"},{"issue":"6","key":"10.1016\/j.pharmthera.2009.11.002_bib322","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/nrd2828","article-title":"Development of pharmacotherapies for drug addiction: a Rosetta stone approach","volume":"8","author":"Koob","year":"2009","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"10.1016\/j.pharmthera.2009.11.002_bib323","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1523\/JNEUROSCI.23-01-00007.2003","article-title":"Excitation of ventral tegmental area dopaminergic and nondopaminergic neurons by orexins\/hypocretins","volume":"23","author":"Korotkova","year":"2003","journal-title":"J Neurosci"},{"issue":"6","key":"10.1016\/j.pharmthera.2009.11.002_bib324","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/0006-3223(92)90223-M","article-title":"Intravenous cocaine challenges during naltrexone maintenance: a preliminary study","volume":"32","author":"Kosten","year":"1992","journal-title":"Biol Psychiatry"},{"issue":"2","key":"10.1016\/j.pharmthera.2009.11.002_bib325","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0376-8716(03)00132-7","article-title":"Aspirin or amiloride for cerebral perfusion defects in cocaine dependence","volume":"71","author":"Kosten","year":"2003","journal-title":"Drug Alcohol Depend"},{"issue":"7\u20138","key":"10.1016\/j.pharmthera.2009.11.002_bib326","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/S0264-410X(01)00425-X","article-title":"Human therapeutic cocaine vaccine: safety and immunogenicity","volume":"20","author":"Kosten","year":"2002","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.pharmthera.2009.11.002_bib327","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0091-3057(00)00443-3","article-title":"Attenuation of morphine dependence and withdrawal by glycine B site antagonists in rats","volume":"68","author":"Kotlinska","year":"2001","journal-title":"Pharmacol Biochem Behav"},{"issue":"1","key":"10.1016\/j.pharmthera.2009.11.002_bib328","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.fbp.0000181600.95405.c7","article-title":"N-methyl-d-aspartate and group I metabotropic glutamate receptors are involved in the expression of ethanol-induced sensitization in mice","volume":"17","author":"Kotlinska","year":"2006","journal-title":"Behav Pharmacol"},{"issue":"3","key":"10.1016\/j.pharmthera.2009.11.002_bib329","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0376-8716(95)01100-D","article-title":"Carbamazepine treatment of cocaine dependence: a placebo-controlled trial","volume":"38","author":"Kranzler","year":"1995","journal-title":"Drug Alcohol Depend"},{"issue":"9","key":"10.1016\/j.pharmthera.2009.11.002_bib330","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1111\/j.1530-0277.1996.tb01696.x","article-title":"Fluoxetine treatment seems to reduce the beneficial effects of cognitive-behavioral therapy in type B alcoholics","volume":"20","author":"Kranzler","year":"1996","journal-title":"Alcohol Clin Exp Res"},{"issue":"8","key":"10.1016\/j.pharmthera.2009.11.002_bib331","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1046\/j.1360-0443.1998.93811614.x","article-title":"Maintenance treatment of opiate addicts in Germany with medications containing codeine-results of a follow-up study","volume":"93","author":"Krausz","year":"1998","journal-title":"Addiction"},{"key":"10.1016\/j.pharmthera.2009.11.002_bib332","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1749-6632.2000.tb06683.x","article-title":"Methadone-related opioid agonist pharmacotherapy for heroin addiction. History, recent molecular and neurochemical research and future in mainstream medicine","volume":"909","author":"Kreek","year":"2000","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"10.1016\/j.pharmthera.2009.11.002_bib333","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/pr.57.1.1","article-title":"Pharmacogenetics and human molecular genetics of opiate and cocaine addictions and their treatments","volume":"57","author":"Kreek","year":"2005","journal-title":"Pharmacol Rev"},{"issue":"4","key":"10.1016\/j.pharmthera.2009.11.002_bib334","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/j.1530-0277.2007.00344.x","article-title":"Antiglutamatergic strategies for ethanol detoxification: comparison with placebo and diazepam","volume":"31","author":"Krupitsky","year":"2007","journal-title":"Alcohol Clin Exp Res"},{"issue":"10","key":"10.1016\/j.pharmthera.2009.11.002_bib335","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1001\/jama.299.10.1121","article-title":"FDA warns of adverse events linked to smoking cessation drug and antiepileptics","volume":"299","author":"Kuehn","year":"2008","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.pharmthera.2009.11.002_bib336","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1038\/sj.npp.1301169","article-title":"The nociceptin\/orphanin FQ receptor agonist Ro 64-6198 reduces alcohol self-administration and prevents relapse-like alcohol drinking","volume":"32","author":"Kuzmin","year":"2007","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.pharmthera.2009.11.002_bib337","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1212\/WNL.51.2.627","article-title":"Topiramate increases cerebral GABA in healthy humans","volume":"51","author":"Kuzniecky","year":"1998","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.pharmthera.2009.11.002_bib338","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/alcalc\/agm136","article-title":"A randomized, multicentre, open-label, comparative trial of disulfiram, naltrexone and acamprosate in the treatment of alcohol dependence","volume":"43","author":"Laaksonen","year":"2008","journal-title":"Alcohol Alcohol"},{"issue":"12","key":"10.1016\/j.pharmthera.2009.11.002_bib339","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.1523\/JNEUROSCI.5129-07.2008","article-title":"Glutamate release in the nucleus accumbens core is necessary for heroin seeking","volume":"28","author":"LaLumiere","year":"2008","journal-title":"J Neurosci"},{"issue":"1","key":"10.1016\/j.pharmthera.2009.11.002_bib340","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1080\/10550490500419169","article-title":"Safety and tolerability of N-acetylcysteine in cocaine-dependent individuals","volume":"15","author":"LaRowe","year":"2006","journal-title":"Am J Addict"},{"issue":"6","key":"10.1016\/j.pharmthera.2009.11.002_bib341","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1038\/sj.bjp.0706789","article-title":"The orexin system regulates alcohol-seeking in rats","volume":"148","author":"Lawrence","year":"2006","journal-title":"Br J Pharmacol"},{"issue":"2","key":"10.1016\/j.pharmthera.2009.11.002_bib342","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/sj.mp.4001202","article-title":"Disruption of nicotine conditioning by dopamine D(3) receptor ligands","volume":"8","author":"Le Foll","year":"2003","journal-title":"Mol Psychiatry"},{"issue":"4","key":"10.1016\/j.pharmthera.2009.11.002_bib343","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/sj.npp.1300622","article-title":"Dopamine D3 receptor ligands block nicotine-induced conditioned place preferences through a mechanism that does not involve discriminative-stimulus or antidepressant-like effects","volume":"30","author":"Le Foll","year":"2005","journal-title":"Neuropsychopharmacology"},{"issue":"5","key":"10.1016\/j.pharmthera.2009.11.002_bib344","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/j.1528-1157.1986.tb03573.x","article-title":"Pharmacological studies on lamotrigine, a novel potential antiepileptic drug: II. Neurochemical studies on the mechanism of action","volume":"27","author":"Leach","year":"1986","journal-title":"Epilepsia"},{"issue":"9","key":"10.1016\/j.pharmthera.2009.11.002_bib345","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/0028-3908(87)90112-2","article-title":"Buprenorphine has potent kappa opioid receptor antagonist activity","volume":"26","author":"Leander","year":"1987","journal-title":"Neuropharmacology"},{"issue":"7","key":"10.1016\/j.pharmthera.2009.11.002_bib346","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1517\/13543784.16.7.935","article-title":"Ibudilast (AV-411). A new class therapeutic candidate for neuropathic pain and opioid withdrawal syndromes","volume":"16","author":"Ledeboer","year":"2007","journal-title":"Expert Opin Investig Drugs"},{"issue":"3","key":"10.1016\/j.pharmthera.2009.11.002_bib347","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1124\/jpet.104.078733","article-title":"Attenuation of behavioral effects of cocaine by the metabotropic glutamate receptor 5 antagonist 2-methyl-6-(phenylethynyl)-pyridine in squirrel monkeys: comparison with dizocilpine","volume":"312","author":"Lee","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"10.1016\/j.pharmthera.2009.11.002_bib348","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/syn.20072","article-title":"Gamma-vinyl GABA (vigabatrin) blocks the expression of toluene-induced conditioned place preference (CPP)","volume":"54","author":"Lee","year":"2004","journal-title":"Synapse"},{"issue":"Suppl 1","key":"10.1016\/j.pharmthera.2009.11.002_bib349","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1360-0443.2005.00988.x","article-title":"Cocaine Rapid Efficacy Screening Trial (CREST): a paradigm for the controlled evaluation of candidate medications for cocaine dependence","volume":"100","author":"Leiderman","year":"2005","journal-title":"Addiction"},{"issue":"6","key":"10.1016\/j.pharmthera.2009.11.002_bib350","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1093\/alcalc\/33.6.563","article-title":"Benzodiazepine treatment for alcohol-dependent patients","volume":"33","author":"Lejoyeux","year":"1998","journal-title":"Alcohol Alcohol"},{"issue":"1","key":"10.1016\/j.pharmthera.2009.11.002_bib351","doi-asserted-by":"crossref","first-page":"E65","DOI":"10.1208\/aapsj080108","article-title":"Current status of immunologic approaches to treating tobacco dependence: vaccines and nicotine-specific antibodies","volume":"8","author":"LeSage","year":"2006","journal-title":"AAPS J"},{"issue":"2","key":"10.1016\/j.pharmthera.2009.11.002_bib352","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1080\/10550490701861177","article-title":"Use of dronabinol for cannabis dependence: two case reports and review","volume":"17","author":"Levin","year":"2008","journal-title":"Am J Addict"},{"issue":"5","key":"10.1016\/j.pharmthera.2009.11.002_bib353","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.neuropharm.2005.11.011","article-title":"The GABA(B) receptor allosteric modulator CGP7930, like baclofen, reduces operant self-administration of ethanol in alcohol-preferring rats","volume":"50","author":"Liang","year":"2006","journal-title":"Neuropharmacology"},{"issue":"2\u20133","key":"10.1016\/j.pharmthera.2009.11.002_bib354","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ejphar.2006.10.011","article-title":"Interactive effects of the mGlu5 receptor antagonist MPEP and the mGlu2\/3 receptor antagonist LY341495 on nicotine self-administration and reward deficits associated with nicotine withdrawal in rats","volume":"554","author":"Liechti","year":"2007","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"10.1016\/j.pharmthera.2009.11.002_bib355","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1007\/s00213-003-1738-x","article-title":"Effects of the dopamine reuptake inhibitor PTT on reinstatement and on food- and cocaine-maintained responding in rhesus monkeys","volume":"174","author":"Lile","year":"2004","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pharmthera.2009.11.002_bib356","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002023","article-title":"Carbamazepine for cocaine dependence","volume":"2","author":"Lima","year":"2002","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.pharmthera.2009.11.002_bib357","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/JCP.0b013e31816727e2","article-title":"Venlafaxine for acute heroin detoxification: a double-blind, randomized, control trial","volume":"28","author":"Lin","year":"2008","journal-title":"J Clin Psychopharmacol"},{"issue":"1","key":"10.1016\/j.pharmthera.2009.11.002_bib358","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.coph.2004.10.002","article-title":"Human brain imaging and substance abuse","volume":"5","author":"Lingford-Hughes","year":"2005","journal-title":"Curr Opin Pharmacol"},{"issue":"3","key":"10.1016\/j.pharmthera.2009.11.002_bib359","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1124\/jpet.300.3.882","article-title":"Reversal of ethanol-seeking behavior by D1 and D2 antagonists in an animal model of relapse: differences in antagonist potency in previously ethanol-dependent versus nondependent rats","volume":"300","author":"Liu","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"issue":"18","key":"10.1016\/j.pharmthera.2009.11.002_bib360","doi-asserted-by":"crossref","first-page":"7856","DOI":"10.1523\/JNEUROSCI.22-18-07856.2002","article-title":"Additive effect of stress and drug cues on reinstatement of ethanol seeking: exacerbation by history of dependence and role of concurrent activation of corticotropin-releasing factor and opioid mechanisms","volume":"22","author":"Liu","year":"2002","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2009.11.002_bib361","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006140.pub2","article-title":"Sustained-release naltrexone for opioid dependence","volume":"2","author":"Lobmaier","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"issue":"1\u20133","key":"10.1016\/j.pharmthera.2009.11.002_bib362","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0167-0115(03)00189-7","article-title":"The effect of chronic CRF1 receptor blockade on the central CCK systems of Fawn-hooded rats","volume":"116","author":"Lodge","year":"2003","journal-title":"Regul Pept"},{"issue":"3","key":"10.1016\/j.pharmthera.2009.11.002_bib363","doi-asserted-by":"crossref","first-page":"480","DOI":"10.4088\/JCP.v69n0321","article-title":"A randomized, double-blind, placebo-controlled trial of long-acting risperidone in cocaine-dependent men","volume":"69","author":"Loebl","year":"2008","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2009.11.002_bib364","first-page":"121","article-title":"Research priorities for psychotherapy and counseling in the treatment of drug abuse: the psychotherapy research perspective","volume":"104","author":"London","year":"1990","journal-title":"NIDA Res Monogr"},{"issue":"2","key":"10.1016\/j.pharmthera.2009.11.002_bib365","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0304-3940(93)90407-C","article-title":"In vivo administration of valproate reduces the nerve terminal (synaptosomal) activity of GABA aminotransferase in discrete brain areas of rats","volume":"160","author":"Loscher","year":"1993","journal-title":"Neurosci Lett"},{"issue":"2","key":"10.1016\/j.pharmthera.2009.11.002_bib366","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0026-895X(25)12934-9","article-title":"Ethanol potentiation of 5-hydroxytryptamine3 receptor-mediated ion current in neuroblastoma cells and isolated adult mammalian neurons","volume":"40","author":"Lovinger","year":"1991","journal-title":"Mol Pharmacol"},{"issue":"3","key":"10.1016\/j.pharmthera.2009.11.002_bib367","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/(SICI)1098-2396(199707)26:3<269::AID-SYN8>3.0.CO;2-5","article-title":"Repeated amphetamine administration alters the expression of mRNA for AMPA receptor subunits in rat nucleus accumbens and prefrontal cortex","volume":"26","author":"Lu","year":"1997","journal-title":"Synapse"},{"issue":"2","key":"10.1016\/j.pharmthera.2009.11.002_bib368","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/bjp.2008.76","article-title":"Inhalant abuse among adolescents: neurobiological considerations","volume":"154","author":"Lubman","year":"2008","journal-title":"Br J Pharmacol"},{"issue":"1","key":"10.1016\/j.pharmthera.2009.11.002_bib369","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1023\/B:CEMN.0000012718.08443.60","article-title":"Cocaine treatment causes early and long-lasting changes in muscarinic and dopaminergic receptors","volume":"24","author":"Macedo","year":"2004","journal-title":"Cell Mol Neurobiol"},{"issue":"3","key":"10.1016\/j.pharmthera.2009.11.002_bib370","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0091-3057(03)00119-9","article-title":"Anti-addictive actions of an iboga alkaloid congener: a novel mechanism for a novel treatment","volume":"75","author":"Maisonneuve","year":"2003","journal-title":"Pharmacol Biochem Behav"},{"issue":"2","key":"10.1016\/j.pharmthera.2009.11.002_bib371","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0376-8716(99)00151-9","article-title":"A double-blind, placebo-controlled outpatient trial of pergolide for cocaine dependence","volume":"60","author":"Malcolm","year":"2000","journal-title":"Drug Alcohol Depend"},{"issue":"5","key":"10.1016\/j.pharmthera.2009.11.002_bib372","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s11606-002-0038-1","article-title":"The effects of carbamazepine and lorazepam on single versus multiple previous alcohol withdrawals in an outpatient randomized trial","volume":"17","author":"Malcolm","year":"2002","journal-title":"J Gen Intern Med"},{"issue":"2","key":"10.1016\/j.pharmthera.2009.11.002_bib373","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jsat.2004.12.006","article-title":"A controlled trial of amlodipine for cocaine dependence: a negative report","volume":"28","author":"Malcolm","year":"2005","journal-title":"J Subst Abuse Treat"},{"issue":"4","key":"10.1016\/j.pharmthera.2009.11.002_bib374","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1080\/00952990600920425","article-title":"Modafinil and cocaine interactions","volume":"32","author":"Malcolm","year":"2006","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"7","key":"10.1016\/j.pharmthera.2009.11.002_bib375","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1111\/j.1530-0277.2008.00690.x","article-title":"Acamprosate: recent findings and future research directions","volume":"32","author":"Mann","year":"2008","journal-title":"Alcohol Clin Exp Res"},{"issue":"10","key":"10.1016\/j.pharmthera.2009.11.002_bib376","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.phymed.2007.06.005","article-title":"Serotonin mediates beneficial effects of Hypericum perforatum on nicotine withdrawal signs","volume":"14","author":"Mannucci","year":"2007","journal-title":"Phytomedicine"},{"issue":"2","key":"10.1016\/j.pharmthera.2009.11.002_bib377","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.pnpbp.2006.10.001","article-title":"An open-label trial of N-acetylcysteine for the treatment of cocaine dependence: a pilot study","volume":"31","author":"Mardikian","year":"2007","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"1","key":"10.1016\/j.pharmthera.2009.11.002_bib378","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.coph.2003.10.003","article-title":"Metabotropic glutamate 2\/3 receptors as drug targets","volume":"4","author":"Marek","year":"2004","journal-title":"Curr Opin Pharmacol"},{"issue":"1","key":"10.1016\/j.pharmthera.2009.11.002_bib379","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3109\/00952999809001700","article-title":"A preliminary investigation of lamotrigine for cocaine abuse in HIV-seropositive patients","volume":"24","author":"Margolin","year":"1998","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"2","key":"10.1016\/j.pharmthera.2009.11.002_bib380","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0376-8716(95)01198-6","article-title":"A multicenter trial of bupropion for cocaine dependence in methadone-maintained patients","volume":"40","author":"Margolin","year":"1995","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"10.1016\/j.pharmthera.2009.11.002_bib381","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.bbr.2008.06.023","article-title":"Food deprivation-like effects of neuropeptide Y on heroin self-administration and reinstatement of heroin seeking in rats","volume":"194","author":"Maric","year":"2008","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pharmthera.2009.11.002_bib382","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1196\/annals.1316.061","article-title":"Role of gamma-aminobutyric acid (GABA) and metabotropic glutamate receptors in nicotine reinforcement: potential pharmacotherapies for smoking cessation","volume":"1025","author":"Markou","year":"2004","journal-title":"Ann N Y Acad Sci"},{"issue":"2","key":"10.1016\/j.pharmthera.2009.11.002_bib383","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.biopsych.2005.04.032","article-title":"Vaccine pharmacotherapy for the treatment of cocaine dependence","volume":"58","author":"Martell","year":"2005","journal-title":"Biol Psychiatry"},{"issue":"2","key":"10.1016\/j.pharmthera.2009.11.002_bib384","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1124\/jpet.106.113571","article-title":"Effects of two novel D3-selective compounds, NGB 2904 [N-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butyl)-9H-fluorene-2-carboxami de] and CJB 090 [N-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butyl)-4-(pyridin-2-yl)benzamide], on the reinforcing and discriminative stimulus effects of cocaine in rhesus monkeys","volume":"321","author":"Martelle","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"issue":"9","key":"10.1016\/j.pharmthera.2009.11.002_bib385","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1097\/00001756-200006260-00026","article-title":"Nociceptin prevents stress-induced ethanol- but not cocaine-seeking behavior in rats","volume":"11","author":"Martin-Fardon","year":"2000","journal-title":"Neuroreport"},{"issue":"1","key":"10.1016\/j.pharmthera.2009.11.002_bib386","first-page":"52","article-title":"Effects of cytidine-5\u2032 diphosphocholine on norepinephrine, dopamine and serotonin synthesis in various regions of the rat brain","volume":"239","author":"Martinet","year":"1979","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"10.1016\/j.pharmthera.2009.11.002_bib387","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/j.1749-6632.2000.tb05213.x","article-title":"Ibogaine: complex pharmacokinetics, concerns for safety, and preliminary efficacy measures","volume":"914","author":"Mash","year":"2000","journal-title":"Ann N Y Acad Sci"},{"issue":"2","key":"10.1016\/j.pharmthera.2009.11.002_bib388","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1017\/S1092852900012827","article-title":"Acamprosate for the treatment of alcohol dependence: a review of double-blind, placebo-controlled trials","volume":"5","author":"Mason","year":"2000","journal-title":"CNS Spectr"},{"issue":"5","key":"10.1016\/j.pharmthera.2009.11.002_bib389","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jpsychires.2006.02.002","article-title":"Effect of oral acamprosate on abstinence in patients with alcohol dependence in a double-blind, placebo-controlled trial: the role of patient motivation","volume":"40","author":"Mason","year":"2006","journal-title":"J Psychiatr Res"},{"issue":"1","key":"10.1016\/j.pharmthera.2009.11.002_bib390","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1369-1600.2008.00133.x","article-title":"Proof-of-concept human laboratory study for protracted abstinence in alcohol dependence: effects of gabapentin","volume":"14","author":"Mason","year":"2009","journal-title":"Addict Biol"},{"key":"10.1016\/j.pharmthera.2009.11.002_bib391","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002207.pub3","article-title":"Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence","volume":"2","author":"Mattick","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"issue":"9","key":"10.1016\/j.pharmthera.2009.11.002_bib392","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1096\/fj.00-0797fje","article-title":"Alcohol consumption is controlled by angiotensin II","volume":"15","author":"Maul","year":"2001","journal-title":"FASEB J"},{"issue":"11","key":"10.1016\/j.pharmthera.2009.11.002_bib393","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1096\/fj.05-3742com","article-title":"Central angiotensin II controls alcohol consumption via its AT1 receptor","volume":"19","author":"Maul","year":"2005","journal-title":"FASEB J"},{"issue":"2","key":"10.1016\/j.pharmthera.2009.11.002_bib394","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1001\/jama.278.2.144","article-title":"Pharmacological management of alcohol withdrawal. A meta-analysis and evidence-based practice guideline. American Society of Addiction Medicine Working Group on Pharmacological Management of Alcohol Withdrawal","volume":"278","author":"Mayo-Smith","year":"1997","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.pharmthera.2009.11.002_bib395","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1111\/j.1530-0277.1995.tb01001.x","article-title":"Association between low contents of dopamine and serotonin in the nucleus accumbens and high alcohol preference","volume":"19","author":"McBride","year":"1995","journal-title":"Alcohol Clin Exp Res"},{"issue":"1","key":"10.1016\/j.pharmthera.2009.11.002_bib396","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0022-3565(25)10557-0","article-title":"Cocaethylene: pharmacology, physiology and behavioral effects in humans","volume":"274","author":"McCance","year":"1995","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2009.11.002_bib397","first-page":"57","article-title":"Desipramine treatment for relapse prevention in cocaine dependence","volume":"95","author":"McElroy","year":"1989","journal-title":"NIDA Res Monogr"},{"issue":"7","key":"10.1016\/j.pharmthera.2009.11.002_bib398","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1523\/JNEUROSCI.4177-03.2004","article-title":"Limbic and motor circuitry underlying footshock-induced reinstatement of cocaine-seeking behavior","volume":"24","author":"McFarland","year":"2004","journal-title":"J Neurosci"},{"issue":"1","key":"10.1016\/j.pharmthera.2009.11.002_bib399","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/sj.bjp.0705059","article-title":"The anti-relapse compound acamprosate inhibits the development of a conditioned place preference to ethanol and cocaine but not morphine","volume":"138","author":"McGeehan","year":"2003","journal-title":"Br J Pharmacol"},{"issue":"3","key":"10.1016\/j.pharmthera.2009.11.002_bib400","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/syn.10166","article-title":"The mGluR5 antagonist MPEP reduces the conditioned rewarding effects of cocaine but not other drugs of abuse","volume":"47","author":"McGeehan","year":"2003","journal-title":"Synapse"},{"issue":"4","key":"10.1016\/j.pharmthera.2009.11.002_bib401","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/01.fbp.0000224384.01863.5f","article-title":"Attenuation of cocaine-induced reinstatement of cocaine conditioned place preference by acamprosate","volume":"17","author":"McGeehan","year":"2006","journal-title":"Behav Pharmacol"},{"issue":"2","key":"10.1016\/j.pharmthera.2009.11.002_bib402","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1007\/s00213-003-1733-2","article-title":"Effect of the mGluR5 antagonist 6-methyl-2-(phenylethynyl)pyridine (MPEP) on the acute locomotor stimulant properties of cocaine, d-amphetamine, and the dopamine reuptake inhibitor GBR12909 in mice","volume":"174","author":"McGeehan","year":"2004","journal-title":"Psychopharmacology (Berl)"},{"issue":"2","key":"10.1016\/j.pharmthera.2009.11.002_bib403","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/bjp.2008.132","article-title":"From ultrasocial to antisocial: a role for oxytocin in the acute reinforcing effects and long-term adverse consequences of drug use?","volume":"154","author":"McGregor","year":"2008","journal-title":"Br J Pharmacol"},{"issue":"5\u20136","key":"10.1016\/j.pharmthera.2009.11.002_bib404","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/00008877-200209000-00019","article-title":"Pharmacokinetic antagonism of (+)-methamphetamine discrimination by a low-affinity monoclonal anti-methamphetamine antibody","volume":"13","author":"McMillan","year":"2002","journal-title":"Behav Pharmacol"},{"issue":"5","key":"10.1016\/j.pharmthera.2009.11.002_bib405","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1080\/10550490600860635","article-title":"Buspirone for treatment of marijuana dependence: a pilot study","volume":"15","author":"McRae","year":"2006","journal-title":"Am J Addict"},{"issue":"2","key":"10.1016\/j.pharmthera.2009.11.002_bib406","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1080\/10550490701862746","article-title":"A pilot open-label trial of ropinirole for cocaine dependence","volume":"17","author":"Meini","year":"2008","journal-title":"Am J Addict"},{"issue":"4","key":"10.1016\/j.pharmthera.2009.11.002_bib407","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.pbb.2006.11.008","article-title":"Effects of the CRF1 antagonist antalarmin on cocaine self-administration and discrimination in rhesus monkeys","volume":"85","author":"Mello","year":"2006","journal-title":"Pharmacol Biochem Behav"},{"issue":"2","key":"10.1016\/j.pharmthera.2009.11.002_bib408","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0006-8993(93)90902-Y","article-title":"Effects of angiotensin II on dopamine and serotonin turnover in the striatum of conscious rats","volume":"613","author":"Mendelsohn","year":"1993","journal-title":"Brain Res"},{"issue":"2","key":"10.1016\/j.pharmthera.2009.11.002_bib409","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1080\/02791072.2007.10399875","article-title":"An open-label pilot study of risperidone in the treatment of methamphetamine dependence","volume":"39","author":"Meredith","year":"2007","journal-title":"J Psychoactive Drugs"},{"issue":"6006","key":"10.1016\/j.pharmthera.2009.11.002_bib410","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/314094a0","article-title":"A functional correlate for the dihydropyridine binding site in rat brain","volume":"314","author":"Middlemiss","year":"1985","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2009.11.002_bib411","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006754.pub2","article-title":"Anticonvulsants for cocaine dependence","volume":"2","author":"Minozzi","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"10.1016\/j.pharmthera.2009.11.002_bib412","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1038\/sj.npp.1301534","article-title":"Modafinil: a review of neurochemical actions and effects on cognition","volume":"33","author":"Minzenberg","year":"2008","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"10.1016\/j.pharmthera.2009.11.002_bib413","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/0301-0082(95)00012-K","article-title":"A physiological role for GABAB receptors and the effects of baclofen in the mammalian central nervous system","volume":"46","author":"Misgeld","year":"1995","journal-title":"Prog Neurobiol"},{"issue":"3","key":"10.1016\/j.pharmthera.2009.11.002_bib414","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1080\/00952990701313686","article-title":"Citalopram combined with behavioral therapy reduces cocaine use: a double-blind, placebo-controlled trial","volume":"33","author":"Moeller","year":"2007","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"2","key":"10.1016\/j.pharmthera.2009.11.002_bib415","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s00213-006-0625-7","article-title":"CP-154, 526, a CRF type-1 receptor antagonist, attenuates the cue-and methamphetamine-induced reinstatement of extinguished methamphetamine-seeking behavior in rats","volume":"190","author":"Moffett","year":"2007","journal-title":"Psychopharmacology (Berl)"},{"issue":"3","key":"10.1016\/j.pharmthera.2009.11.002_bib416","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0376-8716(95)01101-4","article-title":"Double-blind comparison of carbamazepine and placebo for treatment of cocaine dependence","volume":"38","author":"Montoya","year":"1995","journal-title":"Drug Alcohol Depend"},{"issue":"2\u20133","key":"10.1016\/j.pharmthera.2009.11.002_bib417","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.drugalcdep.2006.10.011","article-title":"Safety, tolerability and efficacy of levodopa-carbidopa treatment for cocaine dependence: two double-blind, randomized, clinical trials","volume":"88","author":"Mooney","year":"2007","journal-title":"Drug Alcohol Depend"},{"issue":"1\u20132","key":"10.1016\/j.pharmthera.2009.11.002_bib418","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.drugalcdep.2008.10.016","article-title":"Effects of oral methamphetamine on cocaine use: a randomized, double-blind, placebo-controlled trial","volume":"101","author":"Mooney","year":"2009","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.pharmthera.2009.11.002_bib419","doi-asserted-by":"crossref","first-page":"b1024","DOI":"10.1136\/bmj.b1024","article-title":"Effectiveness and safety of nicotine replacement therapy assisted reduction to stop smoking: systematic review and meta-analysis","volume":"338","author":"Moore","year":"2009","journal-title":"BMJ"},{"issue":"7","key":"10.1016\/j.pharmthera.2009.11.002_bib420","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1111\/j.1530-0277.2007.00399.x","article-title":"Central overexpression of angiotensin AT(1A) receptors prevents dopamine D(2) receptor regulation of alcohol consumption in mice","volume":"31","author":"Moore","year":"2007","journal-title":"Alcohol Clin Exp Res"},{"issue":"9","key":"10.1016\/j.pharmthera.2009.11.002_bib421","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1111\/j.1360-0443.2007.01882.x","article-title":"Rethinking the paradigms that inform behavioral treatment research for substance use disorders","volume":"102","author":"Morgenstern","year":"2007","journal-title":"Addiction"},{"issue":"10","key":"10.1016\/j.pharmthera.2009.11.002_bib422","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1111\/j.1360-0443.2006.01555.x","article-title":"Naltrexone versus acamprosate in the treatment of alcohol dependence: A multi-centre, randomized, double-blind, placebo-controlled trial","volume":"101","author":"Morley","year":"2006","journal-title":"Addiction"},{"issue":"2","key":"10.1016\/j.pharmthera.2009.11.002_bib423","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/nn.2250","article-title":"N-Acetylcysteine reverses cocaine-induced metaplasticity","volume":"12","author":"Moussawi","year":"2009","journal-title":"Nat Neurosci"},{"issue":"1","key":"10.1016\/j.pharmthera.2009.11.002_bib424","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1530-0277.1997.tb03733.x","article-title":"A double-blind, placebo-controlled pilot study of carbamazepine for the treatment of alcohol dependence","volume":"21","author":"Mueller","year":"1997","journal-title":"Alcohol Clin Exp Res"},{"issue":"5","key":"10.1016\/j.pharmthera.2009.11.002_bib425","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1176\/ajp.151.5.701","article-title":"Prognostic effect of the variable course of alcoholism on the 10-year course of depression","volume":"151","author":"Mueller","year":"1994","journal-title":"Am J Psychiatry"},{"issue":"2","key":"10.1016\/j.pharmthera.2009.11.002_bib426","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.neuroscience.2005.09.008","article-title":"Selective down-regulation of [(125)I]Y0-alpha-conotoxin MII binding in rat mesostriatal dopamine pathway following continuous infusion of nicotine","volume":"137","author":"Mugnaini","year":"2006","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/j.pharmthera.2009.11.002_bib427","doi-asserted-by":"crossref","first-page":"48","DOI":"10.4088\/PCC.v10n0108","article-title":"Baclofen in the management of inhalant withdrawal: a case series","volume":"10","author":"Muralidharan","year":"2008","journal-title":"Prim Care Companion J Clin Psychiatry"},{"issue":"10","key":"10.1016\/j.pharmthera.2009.11.002_bib428","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1176\/appi.ajp.160.10.1830","article-title":"Pharmacogenetics of antidepressant medication intolerance","volume":"160","author":"Murphy","year":"2003","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pharmthera.2009.11.002_bib429","first-page":"295","article-title":"Divalproex treatment of cocaine dependence","volume":"179","author":"Myrick","year":"1998","journal-title":"NIDA Res Monogr"},{"issue":"1","key":"10.1016\/j.pharmthera.2009.11.002_bib430","doi-asserted-by":"crossref","first-page":"19","DOI":"10.4088\/JCP.v62n0105","article-title":"Gabapentin in the treatment of cocaine dependence: a case series","volume":"62","author":"Myrick","year":"2001","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2009.11.002_bib431","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1196\/annals.1307.047","article-title":"Involvement of glial glutamate transporters in morphine dependence","volume":"1025","author":"Nakagawa","year":"2004","journal-title":"Ann N Y Acad Sci"},{"issue":"2","key":"10.1016\/j.pharmthera.2009.11.002_bib432","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1523\/JNEUROSCI.2761-05.2006","article-title":"Direct involvement of orexinergic systems in the activation of the mesolimbic dopamine pathway and related behaviors induced by morphine","volume":"26","author":"Narita","year":"2006","journal-title":"J Neurosci"},{"issue":"3","key":"10.1016\/j.pharmthera.2009.11.002_bib433","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.pbb.2008.08.002","article-title":"Effects of the monoamine uptake inhibitors RTI-112 and RTI-113 on cocaine- and food-maintained responding in rhesus monkeys","volume":"91","author":"Negus","year":"2009","journal-title":"Pharmacol Biochem Behav"},{"issue":"1507","key":"10.1016\/j.pharmthera.2009.11.002_bib434","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.1098\/rstb.2008.0067","article-title":"Review. Transcriptional mechanisms of addiction: role of DeltaFosB","volume":"363","author":"Nestler","year":"2008","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"issue":"3","key":"10.1016\/j.pharmthera.2009.11.002_bib435","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/syn.20350","article-title":"Topiramate reduces ethanol consumption by C57BL\/6 mice","volume":"61","author":"Nguyen","year":"2007","journal-title":"Synapse"},{"issue":"4","key":"10.1016\/j.pharmthera.2009.11.002_bib436","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1037\/0022-006X.70.4.887","article-title":"Multicenter trial of fluoxetine as an adjunct to behavioral smoking cessation treatment","volume":"70","author":"Niaura","year":"2002","journal-title":"J Consult Clin Psychol"},{"issue":"1","key":"10.1016\/j.pharmthera.2009.11.002_bib437","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1080\/10550490601080126","article-title":"Treating inhalant abuse with buspirone","volume":"16","author":"Niederhofer","year":"2007","journal-title":"Am J Addict"},{"issue":"11","key":"10.1016\/j.pharmthera.2009.11.002_bib438","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.biopsych.2008.07.018","article-title":"A novel delta opioid receptor antagonist, SoRI-9409, produces a selective and long-lasting decrease in ethanol consumption in heavy-drinking rats","volume":"64","author":"Nielsen","year":"2008","journal-title":"Biol Psychiatry"},{"issue":"1","key":"10.1016\/j.pharmthera.2009.11.002_bib439","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/BF00735892","article-title":"Cocaine-induced place conditioning: importance of route of administration and other procedural variables","volume":"94","author":"Nomikos","year":"1988","journal-title":"Psychopharmacology (Berl)"},{"issue":"1\u20132","key":"10.1016\/j.pharmthera.2009.11.002_bib440","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0006-8993(99)01423-7","article-title":"Priming threshold: a novel quantitative measure of the reinstatement of cocaine self-administration","volume":"831","author":"Norman","year":"1999","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2009.11.002_bib441","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005063.pub2","article-title":"Benzodiazepines for alcohol withdrawal","volume":"3","author":"Ntais","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.pharmthera.2009.11.002_bib442","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/bjp.2008.101","article-title":"Addiction: the clinical interface","volume":"154","author":"Nutt","year":"2008","journal-title":"Br J Pharmacol"},{"issue":"4","key":"10.1016\/j.pharmthera.2009.11.002_bib443","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/j.1530-0277.2007.00347.x","article-title":"Naltrexone and cognitive behavioral coping skills therapy for the treatment of alcohol drinking and eating disorder features in alcohol-dependent women: a randomized controlled trial","volume":"31","author":"O'Malley","year":"2007","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.pharmthera.2009.11.002_bib444","first-page":"172","article-title":"Social and psychological factors underlying inhalant abuse","volume":"85","author":"Oetting","year":"1988","journal-title":"NIDA Res Monogr"},{"issue":"1\u20132","key":"10.1016\/j.pharmthera.2009.11.002_bib445","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0091-3057(01)00748-1","article-title":"Elevated extracellular CRF levels in the bed nucleus of the stria terminalis during ethanol withdrawal and reduction by subsequent ethanol intake","volume":"72","author":"Olive","year":"2002","journal-title":"Pharmacol Biochem Behav"},{"issue":"42","key":"10.1016\/j.pharmthera.2009.11.002_bib446","doi-asserted-by":"crossref","first-page":"7354","DOI":"10.1016\/j.vaccine.2007.08.019","article-title":"Development of an anti-cotinine vaccine to potentiate nicotine-based smoking cessation strategies","volume":"25","author":"Oliver","year":"2007","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.pharmthera.2009.11.002_bib447","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1007\/s11064-005-8836-6","article-title":"Plasticity of GABAA receptors in brains of rats treated with chronic intermittent ethanol","volume":"30","author":"Olsen","year":"2005","journal-title":"Neurochem Res"},{"key":"10.1016\/j.pharmthera.2009.11.002_bib448","first-page":"1","article-title":"Psychotherapy and counseling research in drug abuse treatment: questions, problems, and solutions","volume":"104","author":"Onken","year":"1990","journal-title":"NIDA Res Monogr"},{"issue":"1\u20133","key":"10.1016\/j.pharmthera.2009.11.002_bib449","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ejphar.2005.10.005","article-title":"Reducing effect of the positive allosteric modulators of the GABA(B) receptor, CGP7930 and GS39783, on alcohol intake in alcohol-preferring rats","volume":"525","author":"Orru","year":"2005","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2009.11.002_bib450","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1196\/annals.1441.027","article-title":"Substance abuse vaccines","volume":"1141","author":"Orson","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.pharmthera.2009.11.002_bib451","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1196\/annals.1432.034","article-title":"A role for mGluR5 receptors in intravenous methamphetamine self-administration","volume":"1139","author":"Osborne","year":"2008","journal-title":"Ann N Y Acad Sci"},{"issue":"7","key":"10.1016\/j.pharmthera.2009.11.002_bib452","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1111\/j.1530-0277.2008.00698.x","article-title":"A placebo-controlled randomized clinical trial of naltrexone in the context of different levels of psychosocial intervention","volume":"32","author":"Oslin","year":"2008","journal-title":"Alcohol Clin Exp Res"},{"issue":"2\u20133","key":"10.1016\/j.pharmthera.2009.11.002_bib453","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0014-2999(02)02961-8","article-title":"Influence of prazosin and clonidine on morphine analgesia, tolerance and withdrawal in mice","volume":"460","author":"Ozdogan","year":"2003","journal-title":"Eur J Pharmacol"},{"issue":"5","key":"10.1016\/j.pharmthera.2009.11.002_bib454","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1017\/S1461145706006560","article-title":"The selective dopamine D3 receptor antagonist SB-277011A reduces nicotine-enhanced brain reward and nicotine-paired environmental cue functions","volume":"9","author":"Pak","year":"2006","journal-title":"Int J Neuropsychopharmacol"},{"issue":"9","key":"10.1016\/j.pharmthera.2009.11.002_bib455","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1038\/sj.npp.1301623","article-title":"Metabotropic glutamate 5 receptor (mGluR5) antagonists decrease nicotine seeking, but do not affect the reinforcement enhancing effects of nicotine","volume":"33","author":"Palmatier","year":"2008","journal-title":"Neuropsychopharmacology"},{"issue":"3\u20134","key":"10.1016\/j.pharmthera.2009.11.002_bib456","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s00213-005-0183-4","article-title":"Dissociating the primary reinforcing and reinforcement-enhancing effects of nicotine using a rat self-administration paradigm with concurrently available drug and environmental reinforcers","volume":"184","author":"Palmatier","year":"2006","journal-title":"Psychopharmacology (Berl)"},{"issue":"1\u20133","key":"10.1016\/j.pharmthera.2009.11.002_bib457","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ejphar.2005.09.060","article-title":"Attenuation of morphine withdrawal signs by intracerebral administration of 18-methoxycoronaridine","volume":"525","author":"Panchal","year":"2005","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2009.11.002_bib458","article-title":"An open pilot study of tiagabine in alcohol dependence: tolerability and clinical effects","author":"Paparrigopoulos","year":"2009","journal-title":"J Psychopharmacol"},{"issue":"5","key":"10.1016\/j.pharmthera.2009.11.002_bib459","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0893-133X(02)00349-4","article-title":"Selective blockade of drug-induced place preference conditioning by ACPC, a functional NDMA-receptor antagonist","volume":"27","author":"Papp","year":"2002","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.pharmthera.2009.11.002_bib460","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/S0022-3565(25)10596-X","article-title":"Serotonin dysfunction in the nucleus accumbens of rats during withdrawal after unlimited access to intravenous cocaine","volume":"274","author":"Parsons","year":"1995","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"10.1016\/j.pharmthera.2009.11.002_bib461","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1046\/j.1471-4159.1996.67031078.x","article-title":"Neurochemical evidence that postsynaptic nucleus accumbens D3 receptor stimulation enhances cocaine reinforcement","volume":"67","author":"Parsons","year":"1996","journal-title":"J Neurochem"},{"issue":"1","key":"10.1016\/j.pharmthera.2009.11.002_bib462","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s00213-004-2070-9","article-title":"The metabotropic glutamate receptor 5 antagonist MPEP decreased break points for nicotine, cocaine and food in rats","volume":"179","author":"Paterson","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"issue":"2","key":"10.1016\/j.pharmthera.2009.11.002_bib463","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s00213-003-1637-1","article-title":"The GABAB receptor agonists baclofen and CGP44532 decreased nicotine self-administration in the rat","volume":"172","author":"Paterson","year":"2004","journal-title":"Psychopharmacology (Berl)"},{"issue":"1","key":"10.1016\/j.pharmthera.2009.11.002_bib464","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/sj.npp.1300524","article-title":"Repeated administration of the GABAB receptor agonist CGP44532 decreased nicotine self-administration, and acute administration decreased cue-induced reinstatement of nicotine-seeking in rats","volume":"30","author":"Paterson","year":"2005","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.pharmthera.2009.11.002_bib465","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s00213-003-1432-z","article-title":"The mGluR5 antagonist MPEP decreased nicotine self-administration in rats and mice","volume":"167","author":"Paterson","year":"2003","journal-title":"Psychopharmacology (Berl)"},{"issue":"1","key":"10.1016\/j.pharmthera.2009.11.002_bib466","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1124\/jpet.108.139204","article-title":"Positive modulation of GABA(B) receptors decreased nicotine self-administration and counteracted nicotine-induced enhancement of brain reward function in rats","volume":"326","author":"Paterson","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"10.1016\/j.pharmthera.2009.11.002_bib467","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.drugalcdep.2007.09.019","article-title":"Effects of gabapentin on cocaine self-administration, cocaine-triggered relapse and cocaine-enhanced nucleus accumbens dopamine in rats","volume":"97","author":"Peng","year":"2008","journal-title":"Drug Alcohol Depend"},{"issue":"4","key":"10.1016\/j.pharmthera.2009.11.002_bib468","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.neuropharm.2008.12.007","article-title":"The preferential dopamine D(3) receptor antagonist S33138 inhibits cocaine reward and cocaine-triggered relapse to drug-seeking behavior in rats","volume":"56","author":"Peng","year":"2009","journal-title":"Neuropharmacology"},{"issue":"7","key":"10.1016\/j.pharmthera.2009.11.002_bib469","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1046\/j.1360-0443.2002.00158.x","article-title":"Effects of concurrent use of alcohol and cocaine","volume":"97","author":"Pennings","year":"2002","journal-title":"Addiction"},{"issue":"4","key":"10.1016\/j.pharmthera.2009.11.002_bib470","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1006\/phrs.1997.0124","article-title":"A pharmacological and clinical review on topiramate, a new antiepileptic drug","volume":"35","author":"Perucca","year":"1997","journal-title":"Pharmacol Res"},{"issue":"2","key":"10.1016\/j.pharmthera.2009.11.002_bib471","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1046\/j.1360-0443.2000.9522198.x","article-title":"Disulfiram treatment for cocaine dependence in methadone-maintained opioid addicts","volume":"95","author":"Petrakis","year":"2000","journal-title":"Addiction"},{"issue":"Suppl 20","key":"10.1016\/j.pharmthera.2009.11.002_bib472","first-page":"26","article-title":"The use of selective serotonin reuptake inhibitors in treating alcoholic subtypes","volume":"62","author":"Pettinati","year":"2001","journal-title":"J Clin Psychiatry"},{"issue":"13","key":"10.1016\/j.pharmthera.2009.11.002_bib473","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1016\/0006-2952(82)90111-3","article-title":"The effects of sodium valproate on gamma-aminobutyrate metabolism and behaviour in naive and ethanolamine-O-sulphate pretreated rats and mice","volume":"31","author":"Phillips","year":"1982","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"10.1016\/j.pharmthera.2009.11.002_bib474","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.pbb.2006.04.011","article-title":"Effects of central neurokinin-1 receptor antagonism on cocaine- and opiate-induced locomotor activity and self-administration behaviour in rats","volume":"84","author":"Placenza","year":"2006","journal-title":"Pharmacol Biochem Behav"},{"issue":"2","key":"10.1016\/j.pharmthera.2009.11.002_bib475","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s00213-008-1191-y","article-title":"Attenuation of cocaine self-administration in squirrel monkeys following repeated administration of the mGluR5 antagonist MPEP: comparison with dizocilpine","volume":"200","author":"Platt","year":"2008","journal-title":"Psychopharmacology (Berl)"},{"issue":"11","key":"10.1016\/j.pharmthera.2009.11.002_bib476","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1111\/j.1360-0443.2006.01581.x","article-title":"Contingency management for treatment of substance use disorders: a meta-analysis","volume":"101","author":"Prendergast","year":"2006","journal-title":"Addiction"},{"issue":"2","key":"10.1016\/j.pharmthera.2009.11.002_bib477","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/00008877-200403000-00001","article-title":"Cyclazocine: comparison to hydromorphone and interaction with cocaine","volume":"15","author":"Preston","year":"2004","journal-title":"Behav Pharmacol"},{"issue":"5","key":"10.1016\/j.pharmthera.2009.11.002_bib478","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.npep.2005.07.002","article-title":"Effects of CP 154, 526, a CRF1 receptor antagonist, on behavioral responses to cocaine in rats","volume":"39","author":"Przegalinski","year":"2005","journal-title":"Neuropeptides"},{"issue":"1","key":"10.1016\/j.pharmthera.2009.11.002_bib479","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1210\/jcem-61-1-37","article-title":"Alcohol stimulation of renin release in man: its relation to the hemodynamic, electrolyte, and sympatho-adrenal responses to drinking","volume":"61","author":"Puddey","year":"1985","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.pharmthera.2009.11.002_bib480","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0014-2999(96)00970-3","article-title":"Dextromethorphan reduces intravenous cocaine self-administration in the rat","volume":"321","author":"Pulvirenti","year":"1997","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"10.1016\/j.pharmthera.2009.11.002_bib481","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s00213-007-0802-3","article-title":"The serotonin 2C receptor agonist Ro-60-0175 attenuates effects of nicotine in the five-choice serial reaction time task and in drug discrimination","volume":"193","author":"Quarta","year":"2007","journal-title":"Psychopharmacology (Berl)"},{"issue":"2","key":"10.1016\/j.pharmthera.2009.11.002_bib482","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/(SICI)1098-2396(199710)27:2<145::AID-SYN5>3.0.CO;2-E","article-title":"Serotonin-1A antagonists attenuate the effects of nicotine withdrawal on the auditory startle response","volume":"27","author":"Rasmussen","year":"1997","journal-title":"Synapse"},{"issue":"2","key":"10.1016\/j.pharmthera.2009.11.002_bib483","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/S0022-3565(24)39123-2","article-title":"The novel 5-hydroxytryptamine(1A) antagonist LY426965: effects on nicotine withdrawal and interactions with fluoxetine","volume":"294","author":"Rasmussen","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"10.1016\/j.pharmthera.2009.11.002_bib484","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0006-8993(93)91352-S","article-title":"Microinjection of a corticotropin-releasing factor antagonist into the central nucleus of the amygdala reverses anxiogenic-like effects of ethanol withdrawal","volume":"605","author":"Rassnick","year":"1993","journal-title":"Brain Res"},{"issue":"9","key":"10.1016\/j.pharmthera.2009.11.002_bib485","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1001\/archpsyc.64.9.1069","article-title":"Effects of naltrexone on alcohol sensitivity and genetic moderators of medication response: a double-blind placebo-controlled study","volume":"64","author":"Ray","year":"2007","journal-title":"Arch Gen Psychiatry"},{"issue":"2","key":"10.1016\/j.pharmthera.2009.11.002_bib486","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/(SICI)1098-2396(199710)27:2<95::AID-SYN1>3.0.CO;2-6","article-title":"Cocaine and amphetamine preferentially stimulate glutamate release in the limbic system: studies on the involvement of dopamine","volume":"27","author":"Reid","year":"1997","journal-title":"Synapse"},{"issue":"3","key":"10.1016\/j.pharmthera.2009.11.002_bib487","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0893-133X(98)00076-1","article-title":"A nicotine antagonist, mecamylamine, reduces cue-induced cocaine craving in cocaine-dependent subjects","volume":"20","author":"Reid","year":"1999","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.pharmthera.2009.11.002_bib488","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/(SICI)1098-2396(200002)35:2<129::AID-SYN5>3.0.CO;2-D","article-title":"Nicotine stimulation of extracellular glutamate levels in the nucleus accumbens: neuropharmacological characterization","volume":"35","author":"Reid","year":"2000","journal-title":"Synapse"},{"issue":"1","key":"10.1016\/j.pharmthera.2009.11.002_bib489","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s00213-007-0755-6","article-title":"Effects of topiramate on cue-induced cigarette craving and the response to a smoked cigarette in briefly abstinent smokers","volume":"192","author":"Reid","year":"2007","journal-title":"Psychopharmacology (Berl)"},{"issue":"Suppl 1","key":"10.1016\/j.pharmthera.2009.11.002_bib490","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1360-0443.2005.00990.x","article-title":"A placebo-controlled screening trial of olanzapine, valproate, and coenzyme Q10\/L-carnitine for the treatment of cocaine dependence","volume":"100","author":"Reid","year":"2005","journal-title":"Addiction"},{"issue":"2","key":"10.1016\/j.pharmthera.2009.11.002_bib491","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1300\/J465v26n02_02","article-title":"A placebo controlled, double-blind study of mecamylamine treatment for cocaine dependence in patients enrolled in an opiate replacement program","volume":"26","author":"Reid","year":"2005","journal-title":"Subst Abus"},{"issue":"2","key":"10.1016\/j.pharmthera.2009.11.002_bib492","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/s002130050871","article-title":"Short-term treatment with citicoline (CDP-choline) attenuates some measures of craving in cocaine-dependent subjects: a preliminary report","volume":"142","author":"Renshaw","year":"1999","journal-title":"Psychopharmacology (Berl)"},{"issue":"1","key":"10.1016\/j.pharmthera.2009.11.002_bib493","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s00213-008-1136-5","article-title":"Inhibition of orexin-1\/hypocretin-1 receptors inhibits yohimbine-induced reinstatement of ethanol and sucrose seeking in Long\u2013Evans rats","volume":"199","author":"Richards","year":"2008","journal-title":"Psychopharmacology (Berl)"},{"issue":"6","key":"10.1016\/j.pharmthera.2009.11.002_bib494","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1111\/j.1360-0443.2008.02215.x","article-title":"Do acamprosate or naltrexone have an effect on daily drinking by reducing craving for alcohol?","volume":"103","author":"Richardson","year":"2008","journal-title":"Addiction"},{"issue":"8","key":"10.1016\/j.pharmthera.2009.11.002_bib495","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1038\/sj.npp.1300193","article-title":"Toluene-induced locomotor activity is blocked by 6-hydroxydopamine lesions of the nucleus accumbens and the mGluR2\/3 agonist LY379268","volume":"28","author":"Riegel","year":"2003","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.pharmthera.2009.11.002_bib496","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1360-0443.2008.02454.x","article-title":"A randomized controlled trial of adding the nicotine patch to rimonabant for smoking cessation: efficacy, safety and weight gain","volume":"104","author":"Rigotti","year":"2009","journal-title":"Addiction"},{"issue":"8","key":"10.1016\/j.pharmthera.2009.11.002_bib497","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/S0028-3908(02)00295-2","article-title":"Lack of self-administration and behavioural sensitisation to morphine, but not cocaine, in mice lacking NK1 receptors","volume":"43","author":"Ripley","year":"2002","journal-title":"Neuropharmacology"},{"issue":"4","key":"10.1016\/j.pharmthera.2009.11.002_bib498","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1037\/1064-1297.13.4.319","article-title":"Effects of repeated-dose isradipine on the abuse liability of cocaine","volume":"13","author":"Roache","year":"2005","journal-title":"Exp Clin Psychopharmacol"},{"issue":"25","key":"10.1016\/j.pharmthera.2009.11.002_bib499","doi-asserted-by":"crossref","first-page":"9715","DOI":"10.1073\/pnas.0601899103","article-title":"Nociceptin\/orphanin FQ presynaptically decreases GABAergic transmission and blocks the ethanol-induced increase of GABA release in central amygdala","volume":"103","author":"Roberto","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1\u20132","key":"10.1016\/j.pharmthera.2009.11.002_bib500","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.physbeh.2005.06.017","article-title":"Preclinical evidence for GABAB agonists as a pharmacotherapy for cocaine addiction","volume":"86","author":"Roberts","year":"2005","journal-title":"Physiol Behav"},{"issue":"2","key":"10.1016\/j.pharmthera.2009.11.002_bib501","first-page":"89","article-title":"Buspirone effect on tobacco withdrawal symptoms: a pilot study","volume":"4","author":"Robinson","year":"1991","journal-title":"J Am Board Fam Pract"},{"issue":"1","key":"10.1016\/j.pharmthera.2009.11.002_bib502","first-page":"1","article-title":"Buspirone effect on tobacco withdrawal symptoms: a randomized placebo-controlled trial","volume":"5","author":"Robinson","year":"1992","journal-title":"J Am Board Fam Pract"},{"issue":"4","key":"10.1016\/j.pharmthera.2009.11.002_bib503","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/0306-4603(95)00009-2","article-title":"Ritalin for nicotine withdrawal: Nesbitt's paradox revisited","volume":"20","author":"Robinson","year":"1995","journal-title":"Addict Behav"},{"issue":"2","key":"10.1016\/j.pharmthera.2009.11.002_bib504","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.bbr.2006.03.032","article-title":"The metabotropic glutamate 2\/3 receptor agonist LY404039 reduces alcohol-seeking but not alcohol self-administration in alcohol-preferring (P) rats","volume":"171","author":"Rodd","year":"2006","journal-title":"Behav Brain Res"},{"issue":"7","key":"10.1016\/j.pharmthera.2009.11.002_bib505","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/nrn1430","article-title":"The neurobiology of antiepileptic drugs","volume":"5","author":"Rogawski","year":"2004","journal-title":"Nat Rev Neurosci"},{"issue":"6","key":"10.1016\/j.pharmthera.2009.11.002_bib506","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1111\/j.1365-2125.2008.03270.x","article-title":"Ibudilast in healthy volunteers: safety, tolerability and pharmacokinetics with single and multiple doses","volume":"66","author":"Rolan","year":"2008","journal-title":"Br J Clin Pharmacol"},{"issue":"11 Suppl 6","key":"10.1016\/j.pharmthera.2009.11.002_bib507","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1212\/01.WNL.0000095205.33940.99","article-title":"Anatomy of adenosine A2A receptors in brain: morphological substrates for integration of striatal function","volume":"61","author":"Rosin","year":"2003","journal-title":"Neurology"},{"issue":"2\u20133","key":"10.1016\/j.pharmthera.2009.11.002_bib508","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ejphar.2007.01.004","article-title":"Effects of the selective dopamine D3 receptor antagonist SB-277011A on the reinforcing effects of nicotine as measured by a progressive-ratio schedule in rats","volume":"559","author":"Ross","year":"2007","journal-title":"Eur J Pharmacol"},{"issue":"6","key":"10.1016\/j.pharmthera.2009.11.002_bib509","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1037\/a0014103","article-title":"Dual dopamine\/serotonin releasers: potential treatment agents for stimulant addiction","volume":"16","author":"Rothman","year":"2008","journal-title":"Exp Clin Psychopharmacol"},{"issue":"1","key":"10.1016\/j.pharmthera.2009.11.002_bib510","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.bcp.2007.08.007","article-title":"Dopamine transport inhibitors based on GBR12909 and benztropine as potential medications to treat cocaine addiction","volume":"75","author":"Rothman","year":"2008","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"10.1016\/j.pharmthera.2009.11.002_bib511","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0196-9781(91)90182-O","article-title":"Upregulation of the opioid receptor complex by the chronic administration of morphine: a biochemical marker related to the development of tolerance and dependence","volume":"12","author":"Rothman","year":"1991","journal-title":"Peptides"},{"issue":"3","key":"10.1016\/j.pharmthera.2009.11.002_bib512","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1124\/jpet.104.082503","article-title":"Development of a rationally designed, low abuse potential, biogenic amine releaser that suppresses cocaine self-administration","volume":"313","author":"Rothman","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"10.1016\/j.pharmthera.2009.11.002_bib513","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s00213-008-1186-8","article-title":"Nicotine analog inhibition of nicotine self-administration in rats","volume":"199","author":"Rowland","year":"2008","journal-title":"Psychopharmacology (Berl)"},{"issue":"4","key":"10.1016\/j.pharmthera.2009.11.002_bib514","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0091-3057(96)00393-0","article-title":"Effect of adenosine receptor agonists and antagonists on the expression of opiate withdrawal in rats","volume":"57","author":"Salem","year":"1997","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pharmthera.2009.11.002_bib515","unstructured":"SAMHSA. (2007). 2006 national survey on drug use and health. Retrieved. from."},{"issue":"5","key":"10.1016\/j.pharmthera.2009.11.002_bib516","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1176\/ajp.152.5.778","article-title":"Tryptophan depletion and attenuation of cue-induced craving for cocaine","volume":"152","author":"Satel","year":"1995","journal-title":"Am J Psychiatry"},{"issue":"8","key":"10.1016\/j.pharmthera.2009.11.002_bib517","doi-asserted-by":"crossref","first-page":"969","DOI":"10.4088\/JCP.v64n0819a","article-title":"Olanzapine for cocaine cravings and relapse prevention","volume":"64","author":"Sattar","year":"2003","journal-title":"J Clin Psychiatry"},{"issue":"3","key":"10.1016\/j.pharmthera.2009.11.002_bib518","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s00213-001-0972-3","article-title":"Effects of GBR 12909, WIN 35, 428 and indatraline on cocaine self-administration and cocaine seeking in rats","volume":"160","author":"Schenk","year":"2002","journal-title":"Psychopharmacology (Berl)"},{"issue":"2","key":"10.1016\/j.pharmthera.2009.11.002_bib519","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0306-4603(00)00098-8","article-title":"Naltrexone and relapse prevention treatment for cocaine-dependent patients","volume":"26","author":"Schmitz","year":"2001","journal-title":"Addict Behav"},{"issue":"5","key":"10.1016\/j.pharmthera.2009.11.002_bib520","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/S0009-9236(96)90153-8","article-title":"Efficacy of buspirone in smoking cessation: a placebo-controlled trial","volume":"60","author":"Schneider","year":"1996","journal-title":"Clin Pharmacol Ther"},{"issue":"1\u20132","key":"10.1016\/j.pharmthera.2009.11.002_bib521","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.drugalcdep.2008.04.008","article-title":"A placebo-controlled trial of modafinil for nicotine dependence","volume":"98","author":"Schnoll","year":"2008","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"10.1016\/j.pharmthera.2009.11.002_bib522","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/s00213-005-2175-9","article-title":"The mGluR5 antagonist MPEP decreases operant ethanol self-administration during maintenance and after repeated alcohol deprivations in alcohol-preferring (P) rats","volume":"179","author":"Schroeder","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"issue":"Suppl B","key":"10.1016\/j.pharmthera.2009.11.002_bib523","first-page":"1","article-title":"CDP-choline: pharmacological and clinical review","volume":"17","author":"Secades","year":"1995","journal-title":"Methods Find Exp Clin Pharmacol"},{"issue":"3","key":"10.1016\/j.pharmthera.2009.11.002_bib524","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0091-3057(01)00682-7","article-title":"Neural substrates of conditioned-cued relapse to drug-seeking behavior","volume":"71","author":"See","year":"2002","journal-title":"Pharmacol Biochem Behav"},{"issue":"3","key":"10.1016\/j.pharmthera.2009.11.002_bib525","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s002130000636","article-title":"Dopamine, but not glutamate, receptor blockade in the basolateral amygdala attenuates conditioned reward in a rat model of relapse to cocaine-seeking behavior","volume":"154","author":"See","year":"2001","journal-title":"Psychopharmacology (Berl)"},{"issue":"2","key":"10.1016\/j.pharmthera.2009.11.002_bib526","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0306-4522(02)00665-6","article-title":"Muscarinic receptor antagonism in the basolateral amygdala blocks acquisition of cocaine-stimulus association in a model of relapse to cocaine-seeking behavior in rats","volume":"117","author":"See","year":"2003","journal-title":"Neuroscience"},{"issue":"34","key":"10.1016\/j.pharmthera.2009.11.002_bib527","doi-asserted-by":"crossref","first-page":"8406","DOI":"10.1523\/JNEUROSCI.1958-08.2008","article-title":"Dissociation between rewarding and psychomotor effects of opiates: differential roles for glutamate receptors within anterior and posterior portions of the ventral tegmental area","volume":"28","author":"Shabat-Simon","year":"2008","journal-title":"J Neurosci"},{"issue":"2","key":"10.1016\/j.pharmthera.2009.11.002_bib528","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/s002130050608","article-title":"CP-154, 526, a selective, non-peptide antagonist of the corticotropin-releasing factor1 receptor attenuates stress-induced relapse to drug seeking in cocaine- and heroin-trained rats","volume":"137","author":"Shaham","year":"1998","journal-title":"Psychopharmacology (Berl)"},{"issue":"1","key":"10.1016\/j.pharmthera.2009.11.002_bib529","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/pr.54.1.1","article-title":"Neurobiology of relapse to heroin and cocaine seeking: a review","volume":"54","author":"Shalev","year":"2002","journal-title":"Pharmacol Rev"},{"issue":"3","key":"10.1016\/j.pharmthera.2009.11.002_bib530","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.biopsych.2008.03.006","article-title":"Orexin mediates the expression of precipitated morphine withdrawal and concurrent activation of the nucleus accumbens shell","volume":"64","author":"Sharf","year":"2008","journal-title":"Biol Psychiatry"},{"issue":"8","key":"10.1016\/j.pharmthera.2009.11.002_bib531","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1046\/j.1360-0443.2003.00447.x","article-title":"Pilot randomized double blind placebo-controlled study of dexamphetamine for cocaine dependence","volume":"98","author":"Shearer","year":"2003","journal-title":"Addiction"},{"issue":"9","key":"10.1016\/j.pharmthera.2009.11.002_bib532","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1046\/j.1360-0443.2001.96912898.x","article-title":"Pilot randomized controlled study of dexamphetamine substitution for amphetamine dependence","volume":"96","author":"Shearer","year":"2001","journal-title":"Addiction"},{"issue":"3","key":"10.1016\/j.pharmthera.2009.11.002_bib533","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.pnpbp.2006.12.016","article-title":"Treatment of inhalant dependence with lamotrigine","volume":"31","author":"Shen","year":"2007","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"1","key":"10.1016\/j.pharmthera.2009.11.002_bib534","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1254\/jphs.FM0070177","article-title":"Neuropsychotoxicity of abused drugs: potential of dextromethorphan and novel neuroprotective analogs of dextromethorphan with improved safety profiles in terms of abuse and neuroprotective effects","volume":"106","author":"Shin","year":"2008","journal-title":"J Pharmacol Sci"},{"issue":"3","key":"10.1016\/j.pharmthera.2009.11.002_bib535","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0376-8716(01)00205-8","article-title":"A screening trial of amantadine as a medication for cocaine dependence","volume":"66","author":"Shoptaw","year":"2002","journal-title":"Drug Alcohol Depend"},{"issue":"12","key":"10.1016\/j.pharmthera.2009.11.002_bib536","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.4088\/JCP.v64n1207","article-title":"Randomized placebo-controlled trial of baclofen for cocaine dependence: preliminary effects for individuals with chronic patterns of cocaine use","volume":"64","author":"Shoptaw","year":"2003","journal-title":"J Clin Psychiatry"},{"issue":"Suppl 1","key":"10.1016\/j.pharmthera.2009.11.002_bib537","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1360-0443.2005.00991.x","article-title":"Randomized controlled pilot trial of cabergoline, hydergine and levodopa\/carbidopa: Los Angeles Cocaine Rapid Efficacy Screening Trial (CREST)","volume":"100","author":"Shoptaw","year":"2005","journal-title":"Addiction"},{"issue":"1","key":"10.1016\/j.pharmthera.2009.11.002_bib538","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1300\/J069v27n01_02","article-title":"Bupropion hydrochloride versus placebo, in combination with cognitive behavioral therapy, for the treatment of cocaine abuse\/dependence","volume":"27","author":"Shoptaw","year":"2008","journal-title":"J Addict Dis"},{"issue":"3","key":"10.1016\/j.pharmthera.2009.11.002_bib539","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.drugalcdep.2008.03.010","article-title":"Randomized, placebo-controlled trial of bupropion for the treatment of methamphetamine dependence","volume":"96","author":"Shoptaw","year":"2008","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"10.1016\/j.pharmthera.2009.11.002_bib540","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.drugalcdep.2006.03.005","article-title":"Randomized, placebo-controlled trial of sertraline and contingency management for the treatment of methamphetamine dependence","volume":"85","author":"Shoptaw","year":"2006","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.pharmthera.2009.11.002_bib541","doi-asserted-by":"crossref","first-page":"b1730","DOI":"10.1136\/bmj.b1730","article-title":"Nicotine replacement, effective?","volume":"338","author":"Siegel","year":"2009","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.pharmthera.2009.11.002_bib542","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1093\/alcalc\/36.1.2","article-title":"Evidence about the use of naltrexone and for different ways of using it in the treatment of alcoholism","volume":"36","author":"Sinclair","year":"2001","journal-title":"Alcohol Alcohol"},{"issue":"4","key":"10.1016\/j.pharmthera.2009.11.002_bib543","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s002130100917","article-title":"How does stress increase risk of drug abuse and relapse?","volume":"158","author":"Sinha","year":"2001","journal-title":"Psychopharmacology (Berl)"},{"issue":"2","key":"10.1016\/j.pharmthera.2009.11.002_bib544","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/s002130000499","article-title":"Psychological stress, drug-related cues and cocaine craving","volume":"152","author":"Sinha","year":"2000","journal-title":"Psychopharmacology (Berl)"},{"issue":"1","key":"10.1016\/j.pharmthera.2009.11.002_bib545","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s00213-003-1525-8","article-title":"Hypothalamic-pituitary-adrenal axis and sympatho-adreno-medullary responses during stress-induced and drug cue-induced cocaine craving states","volume":"170","author":"Sinha","year":"2003","journal-title":"Psychopharmacology (Berl)"},{"issue":"1","key":"10.1016\/j.pharmthera.2009.11.002_bib546","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jsat.2004.03.009","article-title":"A double-blind placebo-controlled pilot study of risperidone for decreasing cue-elicited craving in recently withdrawn cocaine dependent patients","volume":"27","author":"Smelson","year":"2004","journal-title":"J Subst Abuse Treat"},{"issue":"1\u20132","key":"10.1016\/j.pharmthera.2009.11.002_bib547","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s00213-003-1706-5","article-title":"Effects of positive allosteric modulators of the GABAB receptor on cocaine self-administration in rats","volume":"173","author":"Smith","year":"2004","journal-title":"Psychopharmacology (Berl)"},{"issue":"1","key":"10.1016\/j.pharmthera.2009.11.002_bib548","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2165\/00023210-200519010-00002","article-title":"Novel approaches to the treatment of cocaine addiction","volume":"19","author":"Sofuoglu","year":"2005","journal-title":"CNS Drugs"},{"issue":"2","key":"10.1016\/j.pharmthera.2009.11.002_bib549","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1369-1600.2008.00138.x","article-title":"Norepinephrine and stimulant addiction","volume":"14","author":"Sofuoglu","year":"2009","journal-title":"Addict Biol"},{"issue":"3","key":"10.1016\/j.pharmthera.2009.11.002_bib550","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.pbb.2005.10.013","article-title":"Tiagabine affects the subjective responses to cocaine in humans","volume":"82","author":"Sofuoglu","year":"2005","journal-title":"Pharmacol Biochem Behav"},{"issue":"3\u20134","key":"10.1016\/j.pharmthera.2009.11.002_bib551","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s00213-005-0296-9","article-title":"Effects of topiramate in combination with intravenous nicotine in overnight abstinent smokers","volume":"184","author":"Sofuoglu","year":"2006","journal-title":"Psychopharmacology (Berl)"},{"issue":"2","key":"10.1016\/j.pharmthera.2009.11.002_bib553","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0091-3057(99)00201-4","article-title":"Effects of labetalol treatment on the physiological and subjective response to smoked cocaine","volume":"65","author":"Sofuoglu","year":"2000","journal-title":"Pharmacol Biochem Behav"},{"issue":"3","key":"10.1016\/j.pharmthera.2009.11.002_bib554","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1007\/s00213-005-0010-y","article-title":"Effects of tiagabine in combination with intravenous nicotine in overnight abstinent smokers","volume":"181","author":"Sofuoglu","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"issue":"4","key":"10.1016\/j.pharmthera.2009.11.002_bib555","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/S0091-3057(03)00157-6","article-title":"Effects of naltrexone and isradipine, alone or in combination, on cocaine responses in humans","volume":"75","author":"Sofuoglu","year":"2003","journal-title":"Pharmacol Biochem Behav"},{"issue":"3","key":"10.1016\/j.pharmthera.2009.11.002_bib556","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.pbb.2008.03.021","article-title":"Disulfiram enhances subjective effects of dextroamphetamine in humans","volume":"90","author":"Sofuoglu","year":"2008","journal-title":"Pharmacol Biochem Behav"},{"issue":"8","key":"10.1016\/j.pharmthera.2009.11.002_bib557","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1177\/070674378703200807","article-title":"Treatment of heroin withdrawal with guanfacine: an open clinical investigation","volume":"32","author":"Soler Insa","year":"1987","journal-title":"Can J Psychiatry"},{"issue":"21","key":"10.1016\/j.pharmthera.2009.11.002_bib558","doi-asserted-by":"crossref","first-page":"5615","DOI":"10.1523\/JNEUROSCI.0027-07.2007","article-title":"Nicotinic alpha 7 receptors as a new target for treatment of cannabis abuse","volume":"27","author":"Solinas","year":"2007","journal-title":"J Neurosci"},{"issue":"3","key":"10.1016\/j.pharmthera.2009.11.002_bib559","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0168-0102(00)00226-1","article-title":"The involvement of glial cells in the development of morphine tolerance","volume":"39","author":"Song","year":"2001","journal-title":"Neurosci Res"},{"issue":"8","key":"10.1016\/j.pharmthera.2009.11.002_bib560","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1111\/j.1460-9568.2004.03682.x","article-title":"Adenosine A2A receptors are involved in physical dependence and place conditioning induced by THC","volume":"20","author":"Soria","year":"2004","journal-title":"Eur J Neurosci"},{"issue":"6","key":"10.1016\/j.pharmthera.2009.11.002_bib561","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1073\/pnas.89.6.2046","article-title":"Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway","volume":"89","author":"Spanagel","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"10.1016\/j.pharmthera.2009.11.002_bib562","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1016\/j.neuropharm.2007.02.012","article-title":"The GABAB receptor agonist baclofen prevents heroin-induced reinstatement of heroin-seeking behavior in rats","volume":"52","author":"Spano","year":"2007","journal-title":"Neuropharmacology"},{"issue":"4","key":"10.1016\/j.pharmthera.2009.11.002_bib563","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s00213-007-0986-6","article-title":"The selective dopamine D3 receptor antagonists SB-277011A and NGB 2904 and the putative partial D3 receptor agonist BP-897 attenuate methamphetamine-enhanced brain stimulation reward in rats","volume":"196","author":"Spiller","year":"2008","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pharmthera.2009.11.002_bib564","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001867.pub2","article-title":"Opioid antagonists for alcohol dependence","volume":"1","author":"Srisurapanont","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.pharmthera.2009.11.002_bib565","article-title":"Lobeline for smoking cessation","volume":"2","author":"Stead","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.pharmthera.2009.11.002_bib566","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD000146.pub3","article-title":"Nicotine replacement therapy for smoking cessation","volume":"1","author":"Stead","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"issue":"30","key":"10.1016\/j.pharmthera.2009.11.002_bib567","doi-asserted-by":"crossref","first-page":"12518","DOI":"10.1073\/pnas.0705368104","article-title":"Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, selectively decreases ethanol consumption and seeking","volume":"104","author":"Steensland","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1\u20133","key":"10.1016\/j.pharmthera.2009.11.002_bib568","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.ejphar.2005.09.031","article-title":"Role of GABAA alpha5-containing receptors in ethanol reward: the effects of targeted gene deletion, and a selective inverse agonist","volume":"526","author":"Stephens","year":"2005","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"10.1016\/j.pharmthera.2009.11.002_bib569","first-page":"125","article-title":"Pathways to relapse: the neurobiology of drug- and stress-induced relapse to drug-taking","volume":"25","author":"Stewart","year":"2000","journal-title":"J Psychiatry Neurosci"},{"issue":"1\u20133","key":"10.1016\/j.pharmthera.2009.11.002_bib570","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.drugalcdep.2007.07.005","article-title":"Safety, tolerability and subject-rated effects of acute intranasal cocaine administration during atomoxetine maintenance","volume":"92","author":"Stoops","year":"2008","journal-title":"Drug Alcohol Depend"},{"issue":"4","key":"10.1016\/j.pharmthera.2009.11.002_bib571","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1080\/105504999305749","article-title":"Lofexidine for opiate detoxification: review of recent randomised and open controlled trials","volume":"8","author":"Strang","year":"1999","journal-title":"Am J Addict"},{"issue":"2","key":"10.1016\/j.pharmthera.2009.11.002_bib572","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1080\/1355621031000117365","article-title":"Ultra-rapid opiate detoxification: from clinical applications to basic science","volume":"8","author":"Streel","year":"2003","journal-title":"Addict Biol"},{"issue":"3","key":"10.1016\/j.pharmthera.2009.11.002_bib573","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/S0022-3565(25)39289-X","article-title":"Nicotinic acetylcholine receptor ion channel blockade by cocaine: the mechanism of synaptic action","volume":"243","author":"Swanson","year":"1987","journal-title":"J Pharmacol Exp Ther"},{"issue":"6","key":"10.1016\/j.pharmthera.2009.11.002_bib574","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/0006-3223(95)00432-7","article-title":"Ondansetron alters human alcohol intoxication","volume":"40","author":"Swift","year":"1996","journal-title":"Biol Psychiatry"},{"issue":"3","key":"10.1016\/j.pharmthera.2009.11.002_bib575","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/hup.677","article-title":"Reboxetine for the treatment of patients with cocaine dependence disorder","volume":"20","author":"Szerman","year":"2005","journal-title":"Hum Psychopharmacol"},{"issue":"1","key":"10.1016\/j.pharmthera.2009.11.002_bib576","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1472-8206.2006.00459.x","article-title":"Preclinical and clinical pharmacology of alcohol dependence","volume":"21","author":"Tambour","year":"2007","journal-title":"Fundam Clin Pharmacol"},{"issue":"3","key":"10.1016\/j.pharmthera.2009.11.002_bib577","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0920-1211(97)00084-3","article-title":"A summary of mechanistic hypotheses of gabapentin pharmacology","volume":"29","author":"Taylor","year":"1998","journal-title":"Epilepsy Res"},{"issue":"5","key":"10.1016\/j.pharmthera.2009.11.002_bib578","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/nn1225","article-title":"Neurobehavioral assessment in the information age","volume":"7","author":"Tecott","year":"2004","journal-title":"Nat Neurosci"},{"issue":"4","key":"10.1016\/j.pharmthera.2009.11.002_bib579","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/0091-3057(94)00438-O","article-title":"Effects of monoamine reuptake inhibitors on cocaine self-administration in rats","volume":"51","author":"Tella","year":"1995","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pharmthera.2009.11.002_bib580","first-page":"239","article-title":"Clinical evaluation of mecamylamine for withdrawal from nicotine dependence","volume":"49","author":"Tennant","year":"1984","journal-title":"NIDA Res Monogr"},{"issue":"1\u20132","key":"10.1016\/j.pharmthera.2009.11.002_bib581","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ejphar.2004.07.056","article-title":"Antagonism at metabotropic glutamate 5 receptors inhibits nicotine- and cocaine-taking behaviours and prevents nicotine-triggered relapse to nicotine-seeking","volume":"499","author":"Tessari","year":"2004","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"10.1016\/j.pharmthera.2009.11.002_bib582","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.pbb.2005.03.013","article-title":"The selective dopamine D3 receptor antagonist SB-277011-A attenuates ethanol consumption in ethanol preferring (P) and non-preferring (NP) rats","volume":"81","author":"Thanos","year":"2005","journal-title":"Pharmacol Biochem Behav"},{"issue":"2","key":"10.1016\/j.pharmthera.2009.11.002_bib583","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.peptides.2006.11.017","article-title":"Neuropeptide Y (NPY) in alcohol intake and dependence","volume":"28","author":"Thorsell","year":"2007","journal-title":"Peptides"},{"issue":"1","key":"10.1016\/j.pharmthera.2009.11.002_bib584","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.bbr.2005.01.016","article-title":"Effects of neuropeptide Y and corticotropin-releasing factor on ethanol intake in Wistar rats: interaction with chronic ethanol exposure","volume":"161","author":"Thorsell","year":"2005","journal-title":"Behav Brain Res"},{"issue":"8","key":"10.1016\/j.pharmthera.2009.11.002_bib585","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1111\/j.1530-0277.2007.00425.x","article-title":"Effect of the adenosine A2a receptor antagonist 3,7-dimethyl-propargylxanthine on anxiety-like and depression-like behavior and alcohol consumption in Wistar Rats","volume":"31","author":"Thorsell","year":"2007","journal-title":"Alcohol Clin Exp Res"},{"issue":"3","key":"10.1016\/j.pharmthera.2009.11.002_bib586","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s00702-006-0570-y","article-title":"Memantine fails to facilitate partial cigarette deprivation in smokers\u2014no role of memantine in the treatment of nicotine dependency?","volume":"114","author":"Thuerauf","year":"2007","journal-title":"J Neural Transm"},{"issue":"1","key":"10.1016\/j.pharmthera.2009.11.002_bib587","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1176\/appi.ajp.164.1.160","article-title":"A comparison of aripiprazole, methylphenidate, and placebo for amphetamine dependence","volume":"164","author":"Tiihonen","year":"2007","journal-title":"Am J Psychiatry"},{"issue":"1\u20133","key":"10.1016\/j.pharmthera.2009.11.002_bib588","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.drugalcdep.2007.10.020","article-title":"Atomoxetine for treatment of marijuana dependence: a report on the efficacy and high incidence of gastrointestinal adverse events in a pilot study","volume":"94","author":"Tirado","year":"2008","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"10.1016\/j.pharmthera.2009.11.002_bib589","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2004.09.004","article-title":"Efficacy of antidepressants in substance use disorders with and without comorbid depression. A systematic review and meta-analysis","volume":"78","author":"Torrens","year":"2005","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"10.1016\/j.pharmthera.2009.11.002_bib590","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/BF00966669","article-title":"Effect of nicotine on extracellular levels of neurotransmitters assessed by microdialysis in various brain regions: role of glutamic acid","volume":"17","author":"Toth","year":"1992","journal-title":"Neurochem Res"},{"issue":"2","key":"10.1016\/j.pharmthera.2009.11.002_bib591","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S0304-3940(98)00023-8","article-title":"Blockade of morphine- and amphetamine-induced conditioned place preference in the rat by riluzole","volume":"242","author":"Tzschentke","year":"1998","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pharmthera.2009.11.002_bib592","series-title":"Medical prescription of narcotics (Vol. 1)","doi-asserted-by":"crossref","DOI":"10.1159\/isbn.978-3-318-00369-7","author":"Uchtenhagen","year":"1999"},{"issue":"6","key":"10.1016\/j.pharmthera.2009.11.002_bib593","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1097\/01.ALC.0000128222.29875.40","article-title":"Increased anxiety-like behavior and ethanol self-administration in dependent rats: reversal via corticotropin-releasing factor-2 receptor activation","volume":"28","author":"Valdez","year":"2004","journal-title":"Alcohol Clin Exp Res"},{"issue":"10","key":"10.1016\/j.pharmthera.2009.11.002_bib594","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1111\/j.1530-0277.2002.tb02448.x","article-title":"Increased ethanol self-administration and anxiety-like behavior during acute ethanol withdrawal and protracted abstinence: regulation by corticotropin-releasing factor","volume":"26","author":"Valdez","year":"2002","journal-title":"Alcohol Clin Exp Res"},{"issue":"2","key":"10.1016\/j.pharmthera.2009.11.002_bib595","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/sj.bjp.0704479","article-title":"Behavioural and biochemical evidence for interactions between Delta 9-tetrahydrocannabinol and nicotine","volume":"135","author":"Valjent","year":"2002","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2009.11.002_bib596","series-title":"Medical co-prescription of heroin: two randomized controlled trials: Central Committee on the Treatment of Heroin Addicts (CCBH)","author":"van den Brink","year":"2002"},{"issue":"9468","key":"10.1016\/j.pharmthera.2009.11.002_bib597","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/S0140-6736(05)66374-X","article-title":"Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study","volume":"365","author":"Van Gaal","year":"2005","journal-title":"Lancet"},{"issue":"13","key":"10.1016\/j.pharmthera.2009.11.002_bib598","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1096\/fj.06-6110com","article-title":"The dopamine D3 receptor plays an essential role in alcohol-seeking and relapse","volume":"20","author":"Vengeliene","year":"2006","journal-title":"FASEB J"},{"issue":"1","key":"10.1016\/j.pharmthera.2009.11.002_bib599","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.pharmthera.2005.06.010","article-title":"Medications development: successes and challenges","volume":"108","author":"Vocci","year":"2005","journal-title":"Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.pharmthera.2009.11.002_bib600","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1053\/snuc.2003.127300","article-title":"Positron emission tomography and single-photon emission computed tomography in substance abuse research","volume":"33","author":"Volkow","year":"2003","journal-title":"Semin Nucl Med"},{"issue":"21","key":"10.1016\/j.pharmthera.2009.11.002_bib601","doi-asserted-by":"crossref","first-page":"9595","DOI":"10.1523\/JNEUROSCI.22-21-09595.2002","article-title":"Dopamine D3 receptor antagonism inhibits cocaine-seeking and cocaine-enhanced brain reward in rats","volume":"22","author":"Vorel","year":"2002","journal-title":"J Neurosci"},{"issue":"5","key":"10.1016\/j.pharmthera.2009.11.002_bib602","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1097\/JCP.0b013e3181858311","article-title":"An open-label study of aripiprazole in nonschizophrenic crack-dependent patients","volume":"28","author":"Vorspan","year":"2008","journal-title":"J Clin Psychopharmacol"},{"issue":"3","key":"10.1016\/j.pharmthera.2009.11.002_bib603","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1360-0443.2005.00998.x","article-title":"Should nortriptyline be used as a first-line aid to help smokers quit? Results from a systematic review and meta-analysis","volume":"100","author":"Wagena","year":"2005","journal-title":"Addiction"},{"issue":"3","key":"10.1016\/j.pharmthera.2009.11.002_bib604","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/sj.npp.1301438","article-title":"Pharmacological evidence for a motivational role of kappa-opioid systems in ethanol dependence","volume":"33","author":"Walker","year":"2008","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.pharmthera.2009.11.002_bib605","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/bjp.2008.32","article-title":"Physiology and pharmacology of alcohol: the imidazobenzodiazepine alcohol antagonist site on subtypes of GABAA receptors as an opportunity for drug development?","volume":"154","author":"Wallner","year":"2008","journal-title":"Br J Pharmacol"},{"issue":"1","key":"10.1016\/j.pharmthera.2009.11.002_bib606","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0022-3565(24)29312-5","article-title":"Enadoline and butorphanol: evaluation of kappa-agonists on cocaine pharmacodynamics and cocaine self-administration in humans","volume":"299","author":"Walsh","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"10.1016\/j.pharmthera.2009.11.002_bib607","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1073\/pnas.0336351100","article-title":"Endocannabinoid signaling via cannabinoid receptor 1 is involved in ethanol preference and its age-dependent decline in mice","volume":"100","author":"Wang","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"10.1016\/j.pharmthera.2009.11.002_bib608","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.tins.2005.10.001","article-title":"Glia: novel counter-regulators of opioid analgesia","volume":"28","author":"Watkins","year":"2005","journal-title":"Trends Neurosci"},{"issue":"3","key":"10.1016\/j.pharmthera.2009.11.002_bib609","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.drugalcdep.2005.05.006","article-title":"Effects of GABAergic modulators on food and cocaine self-administration in baboons","volume":"80","author":"Weerts","year":"2005","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.pharmthera.2009.11.002_bib610","series-title":"Drugs for relapse and prevention of alcoholism","first-page":"135","article-title":"Dopaminergic compounds: preclinical data","author":"Weiss","year":"2005"},{"issue":"11","key":"10.1016\/j.pharmthera.2009.11.002_bib611","doi-asserted-by":"crossref","first-page":"4372","DOI":"10.1523\/JNEUROSCI.12-11-04372.1992","article-title":"Increases in extracellular dopamine in the nucleus accumbens by cocaine are inversely related to basal levels: effects of acute and repeated administration","volume":"12","author":"Weiss","year":"1992","journal-title":"J Neurosci"},{"issue":"10","key":"10.1016\/j.pharmthera.2009.11.002_bib612","doi-asserted-by":"crossref","first-page":"3474","DOI":"10.1523\/JNEUROSCI.16-10-03474.1996","article-title":"Ethanol self-administration restores withdrawal-associated deficiencies in accumbal dopamine and 5-hydroxytryptamine release in dependent rats","volume":"16","author":"Weiss","year":"1996","journal-title":"J Neurosci"},{"issue":"3","key":"10.1016\/j.pharmthera.2009.11.002_bib613","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/00002826-198706000-00008","article-title":"Carbamazepine and carbamazepine-10, 11-epoxide inhibit amygdala-kindled seizures in the rat but do not block their development","volume":"10","author":"Weiss","year":"1987","journal-title":"Clin Neuropharmacol"},{"issue":"1","key":"10.1016\/j.pharmthera.2009.11.002_bib614","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/BF02246417","article-title":"Randomised controlled trial of ondansetron in smoking cessation","volume":"126","author":"West","year":"1996","journal-title":"Psychopharmacology (Berl)"},{"issue":"1","key":"10.1016\/j.pharmthera.2009.11.002_bib615","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/BF02244560","article-title":"Effect of buspirone on cigarette withdrawal symptoms and short-term abstinence rates in a smokers clinic","volume":"104","author":"West","year":"1991","journal-title":"Psychopharmacology (Berl)"},{"issue":"5","key":"10.1016\/j.pharmthera.2009.11.002_bib616","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1080\/14622200500259887","article-title":"A randomized, open-label pilot comparison of gabapentin and bupropion SR for smoking cessation","volume":"7","author":"White","year":"2005","journal-title":"Nicotine Tob Res"},{"key":"10.1016\/j.pharmthera.2009.11.002_bib617","series-title":"Statistics on the global burden of substance abuse","year":"2002"},{"issue":"1","key":"10.1016\/j.pharmthera.2009.11.002_bib618","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/sj.npp.1300290","article-title":"Alterations in central neuropeptide expression, release, and receptor binding in rats bred for high anxiety: critical role of vasopressin","volume":"29","author":"Wigger","year":"2004","journal-title":"Neuropsychopharmacology"},{"issue":"8","key":"10.1016\/j.pharmthera.2009.11.002_bib619","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1038\/sj.npp.1301585","article-title":"The role of acetylcholine in cocaine addiction","volume":"33","author":"Williams","year":"2008","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"10.1016\/j.pharmthera.2009.11.002_bib620","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.pbb.2005.01.017","article-title":"Metyrapone and cocaine: a double-blind, placebo-controlled drug interaction study","volume":"80","author":"Winhusen","year":"2005","journal-title":"Pharmacol Biochem Behav"},{"issue":"2\u20133","key":"10.1016\/j.pharmthera.2009.11.002_bib621","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.drugalcdep.2007.05.021","article-title":"A double-blind, placebo-controlled trial of reserpine for the treatment of cocaine dependence","volume":"91","author":"Winhusen","year":"2007","journal-title":"Drug Alcohol Depend"},{"issue":"2\u20133","key":"10.1016\/j.pharmthera.2009.11.002_bib622","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.drugalcdep.2007.05.028","article-title":"A double-blind, placebo-controlled trial of tiagabine for the treatment of cocaine dependence","volume":"91","author":"Winhusen","year":"2007","journal-title":"Drug Alcohol Depend"},{"issue":"Suppl 1","key":"10.1016\/j.pharmthera.2009.11.002_bib623","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1360-0443.2005.00992.x","article-title":"A placebo-controlled screening trial of tiagabine, sertraline and donepezil as cocaine dependence treatments","volume":"100","author":"Winhusen","year":"2005","journal-title":"Addiction"},{"issue":"1","key":"10.1016\/j.pharmthera.2009.11.002_bib624","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1177\/0269881108089584","article-title":"Lithium carbonate in the management of cannabis withdrawal in humans: an open-label study","volume":"23","author":"Winstock","year":"2009","journal-title":"J Psychopharmacol"},{"issue":"2","key":"10.1016\/j.pharmthera.2009.11.002_bib625","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1369-1600.2008.00109.x","article-title":"The role of CB1 receptors in psychostimulant addiction","volume":"13","author":"Wiskerke","year":"2008","journal-title":"Addict Biol"},{"issue":"3","key":"10.1016\/j.pharmthera.2009.11.002_bib626","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/00008877-199504000-00005","article-title":"Effects of ifenprodil on stimulatory, discriminative stimulus, and convulsant effects of cocaine","volume":"6","author":"Witkin","year":"1995","journal-title":"Behav Pharmacol"},{"issue":"4","key":"10.1016\/j.pharmthera.2009.11.002_bib627","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/0091-3057(86)90416-8","article-title":"Elevations in plasma angiotensin II with prolonged ethanol treatment in rats","volume":"24","author":"Wright","year":"1986","journal-title":"Pharmacol Biochem Behav"},{"issue":"2","key":"10.1016\/j.pharmthera.2009.11.002_bib628","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S0022-3565(24)39113-X","article-title":"Increased mesolimbic GABA concentration blocks heroin self-administration in the rat","volume":"294","author":"Xi","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"10.1016\/j.pharmthera.2009.11.002_bib629","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1527-3458.2007.00013.x","article-title":"Pharmacological actions of NGB 2904, a selective dopamine D3 receptor antagonist, in animal models of drug addiction","volume":"13","author":"Xi","year":"2007","journal-title":"CNS Drug Rev"},{"issue":"1","key":"10.1016\/j.pharmthera.2009.11.002_bib630","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1124\/jpet.300.1.162","article-title":"Group II metabotropic glutamate receptors modulate extracellular glutamate in the nucleus accumbens","volume":"300","author":"Xi","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"10.1016\/j.pharmthera.2009.11.002_bib631","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s00213-004-1858-y","article-title":"Blockade of mesolimbic dopamine D3 receptors inhibits stress-induced reinstatement of cocaine-seeking in rats","volume":"176","author":"Xi","year":"2004","journal-title":"Psychopharmacology (Berl)"},{"issue":"7","key":"10.1016\/j.pharmthera.2009.11.002_bib632","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1038\/sj.npp.1300912","article-title":"The novel dopamine D3 receptor antagonist NGB 2904 inhibits cocaine's rewarding effects and cocaine-induced reinstatement of drug-seeking behavior in rats","volume":"31","author":"Xi","year":"2006","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.pharmthera.2009.11.002_bib633","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1017\/S1461145799001480","article-title":"Differential changes in glutamatergic transmission via N-methyl-d-aspartate receptors in the hippocampus and striatum of rats behaviourally sensitized to methamphetamine","volume":"2","author":"Yamamoto","year":"1999","journal-title":"Int J Neuropsychopharmacol"},{"issue":"20","key":"10.1016\/j.pharmthera.2009.11.002_bib634","doi-asserted-by":"crossref","first-page":"7877","DOI":"10.1073\/pnas.0602661103","article-title":"Adenosine A2a blockade prevents synergy between mu-opiate and cannabinoid CB1 receptors and eliminates heroin-seeking behavior in addicted rats","volume":"103","author":"Yao","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.pharmthera.2009.11.002_bib635","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.neulet.2007.09.034","article-title":"Potential roles of GABA receptors in morphine self-administration in rats","volume":"428","author":"Yoon","year":"2007","journal-title":"Neurosci Lett"},{"issue":"36","key":"10.1016\/j.pharmthera.2009.11.002_bib636","doi-asserted-by":"crossref","first-page":"9021","DOI":"10.1523\/JNEUROSCI.0694-08.2008","article-title":"Acetylcholine release in the mesocorticolimbic dopamine system during cocaine seeking: conditioned and unconditioned contributions to reward and motivation","volume":"28","author":"You","year":"2008","journal-title":"J Neurosci"},{"issue":"1","key":"10.1016\/j.pharmthera.2009.11.002_bib637","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/01.ALC.0000150007.34702.16","article-title":"Mecamylamine and ethanol preference in healthy volunteers","volume":"29","author":"Young","year":"2005","journal-title":"Alcohol Clin Exp Res"},{"issue":"1\u20132","key":"10.1016\/j.pharmthera.2009.11.002_bib638","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.drugalcdep.2008.04.002","article-title":"A Phase 3 placebo-controlled, double-blind, multi-site trial of the alpha-2-adrenergic agonist, lofexidine, for opioid withdrawal","volume":"97","author":"Yu","year":"2008","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"10.1016\/j.pharmthera.2009.11.002_bib639","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/0091-3057(93)90479-D","article-title":"Effects of 5-hydroxytryptamine3 antagonist, ondansetron, on cigarette smoking, smoke exposure, and mood in humans","volume":"44","author":"Zacny","year":"1993","journal-title":"Pharmacol Biochem Behav"},{"issue":"4","key":"10.1016\/j.pharmthera.2009.11.002_bib640","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/S0091-3057(02)00951-6","article-title":"Effect of imipramine on the expression and acquisition of morphine-induced conditioned place preference in mice","volume":"73","author":"Zarrindast","year":"2002","journal-title":"Pharmacol Biochem Behav"},{"issue":"3","key":"10.1016\/j.pharmthera.2009.11.002_bib641","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.pain.2007.05.023","article-title":"IL-1ra alleviates inflammatory hyperalgesia through preventing phosphorylation of NMDA receptor NR-1 subunit in rats","volume":"135","author":"Zhang","year":"2008","journal-title":"Pain"},{"issue":"39","key":"10.1016\/j.pharmthera.2009.11.002_bib642","doi-asserted-by":"crossref","first-page":"9967","DOI":"10.1523\/JNEUROSCI.2384-06.2006","article-title":"Activation of group II metabotropic glutamate receptors attenuates both stress and cue-induced ethanol-seeking and modulates c-fos expression in the hippocampus and amygdala","volume":"26","author":"Zhao","year":"2006","journal-title":"J Neurosci"},{"issue":"3","key":"10.1016\/j.pharmthera.2009.11.002_bib643","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.biopsych.2007.06.008","article-title":"N-acetylcysteine reduces extinction responding and induces enduring reductions in cue- and heroin-induced drug-seeking","volume":"63","author":"Zhou","year":"2008","journal-title":"Biol Psychiatry"},{"issue":"4","key":"10.1016\/j.pharmthera.2009.11.002_bib644","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.neuroscience.2006.11.013","article-title":"Role of acetylcholine transmission in nucleus accumbens and ventral tegmental area in heroin-seeking induced by conditioned cues","volume":"144","author":"Zhou","year":"2007","journal-title":"Neuroscience"},{"issue":"2","key":"10.1016\/j.pharmthera.2009.11.002_bib645","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/sj.npp.1301419","article-title":"Involvement of arginine vasopressin and V1b receptor in heroin withdrawal and heroin seeking precipitated by stress and by heroin","volume":"33","author":"Zhou","year":"2008","journal-title":"Neuropsychopharmacology"}],"container-title":["Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725809002125?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725809002125?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T07:13:09Z","timestamp":1739430789000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725809002125"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":644,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["S0163725809002125"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2009.11.002","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]}}}